data_2k6h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.43 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt . . . . . 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 122.576 1.179 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 111' ' ' PHE . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt . . . . . 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 122.767 1.27 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -89.49 -18.56 26.47 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.046 1.748 . . . . 0.0 113.947 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 125.76 33.47 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.69 94.77 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -138.28 -176.69 4.54 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -52.7 -32.34 42.24 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.6 mmt -125.59 140.58 52.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.059 1.744 . . . . 0.0 107.477 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.6 tp -157.72 149.43 21.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.185 1.394 . . . . 0.0 107.95 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -78.43 -52.03 1.46 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.84 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -75.91 59.53 5.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.873 2.382 . . . . 0.0 114.004 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -51.71 67.45 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.432 -1.418 . . . . 0.0 111.387 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.19 75.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.667 0.667 . . . . 0.0 111.696 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.21 -50.34 34.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.677 0.791 . . . . 0.0 109.528 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -101.57 118.33 36.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.1 t -62.73 147.68 48.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.7 m -79.89 79.09 6.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.588 0.755 . . . . 0.0 109.151 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -79.61 -99.69 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.06 0.944 . . . . 0.0 108.848 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -148.89 152.79 37.04 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 108.418 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.353 1.461 . . . . 0.0 107.919 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 62.38 0.6 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.189 1.396 . . . . 0.0 109.135 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -137.75 100.77 4.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.246 1.418 . . . . 0.0 107.218 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.94 101.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 163.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.43 ' HB3' ' HZ3' ' A' ' 155' ' ' LYS . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -72.6 -21.55 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -143.52 159.31 42.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.001 1.721 . . . . 0.0 107.83 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 18.3 mmt -86.04 96.15 9.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.384 1.073 . . . . 0.0 109.368 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.4 tp -72.36 170.87 13.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.812 0.845 . . . . 0.0 109.735 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -53.83 142.4 44.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.668 1.587 . . . . 0.0 111.152 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.04 21.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.989 4.459 . . . . 0.0 117.395 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.72 -30.04 70.66 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.582 -1.324 . . . . 0.0 111.743 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.98 155.12 35.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.969 0.507 . . . . 0.0 109.699 172.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.39 41.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.787 1.635 . . . . 0.0 111.206 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 111' ' ' PHE . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -103.06 90.63 3.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.4 m -50.17 -46.88 54.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.69 1.596 . . . . 0.0 112.259 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.4 m -142.06 150.07 40.77 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.21 105.38 2.48 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.26 67.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.068 0.547 . . . . 0.0 112.182 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.677 1.591 . . . . 0.0 108.071 177.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.506 0.193 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.5 17.68 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.469 1.508 . . . . 0.0 114.659 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -129.4 127.77 41.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.266 1.826 . . . . 0.0 107.328 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.84 120.06 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -79.44 -13.44 59.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -135.4 164.44 27.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.214 2.206 . . . . 0.0 106.869 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.28 -8.18 16.71 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 30.1 tp -75.49 64.98 1.67 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.339 1.856 . . . . 0.0 111.265 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.06 84.6 3.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.913 157.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.44 -12.71 11.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.764 2.31 . . . . 0.0 113.284 171.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -63.84 -27.26 69.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -154.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.12 84.62 1.93 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 110.234 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.3 28.36 15.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.928 1.691 . . . . 0.0 113.55 162.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -130.65 100.52 5.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.6 m -58.93 -32.36 69.51 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.865 0.866 . . . . 0.0 111.698 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 p -138.15 135.87 36.12 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.29 1.836 . . . . 0.0 107.783 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.48 -19.8 45.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -152.4 98.7 2.42 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.736 1.214 . . . . 0.0 108.137 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 172.335 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.942 -0.075 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -77.17 62.09 2.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -162.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.71 165.82 18.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 109.817 155.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.82 97.5 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -75.84 -23.83 55.77 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -142.25 157.65 44.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.029 2.532 . . . . 0.0 106.637 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 113.2 4.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.8 tp -135.2 139.14 44.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.071 1.348 . . . . 0.0 107.745 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 33.12 62.24 1.53 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.464 2.305 . . . . 0.0 114.387 -171.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.75 -4.32 6.99 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.969 3.113 . . . . 0.0 115.622 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -106.66 -3.83 20.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.022 1.329 . . . . 0.0 112.07 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.69 -112.51 0.33 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.164 0.893 . . . . 0.0 110.352 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.35 -41.5 89.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 111.363 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -135.71 98.21 3.86 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.2 m -57.59 149.43 21.5 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.842 0.857 . . . . 0.0 109.192 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -65.84 92.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.754 1.222 . . . . 0.0 109.124 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.88 104.2 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.245 1.018 . . . . 0.0 108.958 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.36 91.88 2.25 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 172.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.074 1.75 . . . . 0.0 108.073 179.096 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.27 35.15 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.669 1.988 . . . . 0.0 114.199 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.85 80.34 1.8 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.111 1.765 . . . . 0.0 107.183 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.11 123.66 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.8 -88.27 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -73.17 -21.56 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.68 89.33 1.76 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -121.3 9.61 10.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 111.974 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -62.98 116.83 27.26 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.432 1.493 . . . . 0.0 110.128 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.63 -20.48 58.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.829 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -66.53 -26.99 67.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.041 0.937 . . . . 0.0 111.533 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.32 143.96 51.85 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.12 9.02 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.511 1.524 . . . . 0.0 113.553 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -77.57 52.34 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.5 t -74.35 -37.49 63.49 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -64.53 128.62 36.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.184 1.394 . . . . 0.0 109.321 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -65.97 -35.87 81.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.681 0.393 . . . . 0.0 111.384 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.28 102.85 3.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.401 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 169.014 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.96 62.66 1.64 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.038 1.335 . . . . 0.0 112.75 -176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -113.73 169.11 9.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.134 1.773 . . . . 0.0 108.348 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 129.51 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 128.33 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.26 -68.72 0.42 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 162.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -71.25 152.62 43.12 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 59.1 tp -146.36 80.23 1.56 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.59 73.03 9.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.455 0.702 . . . . 0.0 110.914 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.92 -8.52 22.83 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.439 2.759 . . . . 0.0 114.882 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.45 -19.52 62.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.315 1.446 . . . . 0.0 113.102 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.36 -171.28 1.73 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.895 1.278 . . . . 0.0 111.975 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.9 2.98 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.211 1.805 . . . . 0.0 113.477 170.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -143.43 93.08 2.44 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 t -67.02 126.73 30.07 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.8 m -141.57 159.0 43.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.58 1.552 . . . . 0.0 107.703 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.46 81.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.038 0.935 . . . . 0.0 112.028 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.2 43.61 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.159 1.384 . . . . 0.0 107.674 176.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -11.34 60.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -108.72 153.8 22.94 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.285 . . . . 0.0 109.704 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.01 133.63 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -79.14 -24.85 43.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -136.19 -174.32 3.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.336 2.254 . . . . 0.0 108.242 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.31 25.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.712 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.5 tt 13.81 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 131.224 3.81 . . . . 0.0 114.304 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.61 71.69 1.04 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.925 2.09 . . . . 0.0 112.148 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.65 -37.82 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.313 2.008 . . . . 0.0 112.891 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -92.37 -14.36 28.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.63 1.172 . . . . 0.0 112.519 -166.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.78 -167.8 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.33 1.062 . . . . 0.0 111.408 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.18 -6.27 2.95 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.973 1.309 . . . . 0.0 112.278 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -78.48 68.36 4.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.3 t -71.21 -39.18 71.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 m -65.85 136.08 55.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.777 1.231 . . . . 0.0 109.469 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.74 166.96 14.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.21 0.604 . . . . 0.0 110.789 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.49 85.32 3.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.173 0.989 . . . . 0.0 109.421 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 167.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.27 4.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -135.25 160.09 39.49 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.411 1.884 . . . . 0.0 108.649 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.11 154.41 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -55.76 116.82 3.15 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 46.72 26.26 0.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.651 2.38 . . . . 0.0 115.402 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.4 mmt -129.25 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.952 1.251 . . . . 0.0 111.017 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.2 tp -148.1 107.54 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 127.663 2.385 . . . . 0.0 104.636 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -116.45 94.01 41.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.425 1.09 . . . . 0.0 108.197 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.27 -25.65 73.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.845 2.363 . . . . 0.0 113.718 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -74.95 -16.85 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 112.031 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.83 164.68 16.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.916 0.78 . . . . 0.0 110.438 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -92.07 19.46 6.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.766 1.626 . . . . 0.0 111.671 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -117.18 32.62 6.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.0 m -57.79 -34.41 69.58 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.108 -0.995 . . . . 0.0 110.765 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.3 m -60.51 115.0 3.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.161 1.384 . . . . 0.0 109.796 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.34 62.98 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -105.78 103.68 13.23 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.263 1.425 . . . . 0.0 108.268 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttm 68.87 14.42 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.039 2.136 . . . . 0.0 114.01 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -107.92 172.88 6.58 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.401 1.001 . . . . 0.0 110.659 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.72 133.34 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -131.83 16.55 4.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -122.18 148.27 45.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.679 1.592 . . . . 0.0 107.592 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 38.78 0.31 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.738 1.615 . . . . 0.0 111.867 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.4 157.08 44.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.887 1.275 . . . . 0.0 109.098 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.34 91.87 2.1 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.032 1.333 . . . . 0.0 109.209 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.58 -71.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.999 2.466 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -104.37 -6.57 20.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.752 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.49 -26.77 66.53 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.018 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.1 33.45 4.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.099 1.76 . . . . 0.0 112.54 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -78.99 -46.82 17.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.5 m -39.56 107.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.145 2.578 . . . . 0.0 111.931 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.25 41.2 p 52.88 -0.19 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.338 3.055 . . . . 0.0 116.264 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.83 16.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.953 1.301 . . . . 0.0 110.994 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -149.31 162.35 40.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.422 1.089 . . . . 0.0 110.039 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.854 1.662 . . . . 0.0 108.252 178.052 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.993 0.425 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.41 -7.48 32.03 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -78.92 81.74 5.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.38 142.05 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -0.45 10.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -165.71 117.86 1.11 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.463 1.505 . . . . 0.0 107.285 160.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.27 173.29 15.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.764 0.826 . . . . 0.0 111.309 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 52.6 tp -144.08 -52.98 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.401 1.08 . . . . 0.0 109.807 159.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -141.97 81.01 14.9 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.19 -89.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.044 2.496 . . . . 0.0 110.684 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.9 -42.98 13.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.52 -179.21 7.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.256 1.422 . . . . 0.0 110.261 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.41 99.79 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.352 1.861 . . . . 0.0 109.906 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -88.58 119.11 28.74 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 2.3 m -67.33 -31.55 71.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.416 0.553 . . . . 0.0 110.497 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -150.47 167.43 27.18 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.91 1.284 . . . . 0.0 108.571 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.64 115.33 8.76 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.55 133.48 55.87 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 C-N-CA 125.99 1.716 . . . . 0.0 107.587 174.226 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 135' ' ' THR . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 119' ' ' ILE . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 64' ' ' THR . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 32' ' ' VAL . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 39' ' ' HIS . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 71' ' ' LEU . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt . . . . . 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 122.576 1.179 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.537 ' CG ' HG12 ' A' ' 198' ' ' VAL . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 171' ' ' PHE . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 78' ' ' LEU . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.558 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.447 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 75' ' ' MET . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 159' ' ' VAL . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 124' ' ' LEU . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 118' ' ' LEU . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 118' ' ' LEU . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 224' ' ' LYS . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.416 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt . . . . . 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.465 HG21 HG11 ' A' ' 237' ' ' VAL . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 204' ' ' ILE . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 159' ' ' VAL . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 124' ' ' LEU . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 118' ' ' LEU . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 118' ' ' LEU . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 118' ' ' LEU . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 237' ' ' VAL . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 224' ' ' LYS . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 204' ' ' ILE . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 159' ' ' VAL . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 118' ' ' LEU 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 167' ' ' GLU . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.438 ' CD2' HG22 ' A' ' 237' ' ' VAL . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 171' ' ' PHE . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.455 ' CE2' HG22 ' A' ' 178' ' ' VAL . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 102' ' ' LEU . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 90' ' ' TRP . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.435 ' H ' ' HE3' ' A' ' 129' ' ' MET . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 122.767 1.27 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 162' ' ' VAL . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 159' ' ' VAL . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.418 ' CG ' HG21 ' A' ' 178' ' ' VAL . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.543 ' CD1' HG12 ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 198' ' ' VAL . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 21' ' ' TYR . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 174' ' ' VAL . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 62' ' ' LEU . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 162' ' ' VAL . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' TRP . . . . . 0.431 ' CD2' HD12 ' A' ' 219' ' ' ILE . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 211' ' ' TRP . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 236' ' ' ILE . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 227' ' ' ILE 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -89.49 -18.56 26.47 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.046 1.748 . . . . 0.0 113.947 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 125.76 33.47 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.69 94.77 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 135' ' ' THR . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 119' ' ' ILE . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 64' ' ' THR . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -138.28 -176.69 4.54 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -52.7 -32.34 42.24 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.6 mmt -125.59 140.58 52.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.059 1.744 . . . . 0.0 107.477 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.6 tp -157.72 149.43 21.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.185 1.394 . . . . 0.0 107.95 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -78.43 -52.03 1.46 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.84 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -75.91 59.53 5.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.873 2.382 . . . . 0.0 114.004 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -51.71 67.45 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.432 -1.418 . . . . 0.0 111.387 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.19 75.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.667 0.667 . . . . 0.0 111.696 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.21 -50.34 34.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.677 0.791 . . . . 0.0 109.528 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -101.57 118.33 36.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.1 t -62.73 147.68 48.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.7 m -79.89 79.09 6.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.588 0.755 . . . . 0.0 109.151 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -79.61 -99.69 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.06 0.944 . . . . 0.0 108.848 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -148.89 152.79 37.04 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 108.418 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.353 1.461 . . . . 0.0 107.919 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 62.38 0.6 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.189 1.396 . . . . 0.0 109.135 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -137.75 100.77 4.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.246 1.418 . . . . 0.0 107.218 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.94 101.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 163.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 32' ' ' VAL . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 39' ' ' HIS . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 71' ' ' LEU . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -72.6 -21.55 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -143.52 159.31 42.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.001 1.721 . . . . 0.0 107.83 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 18.3 mmt -86.04 96.15 9.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.384 1.073 . . . . 0.0 109.368 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.4 tp -72.36 170.87 13.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.812 0.845 . . . . 0.0 109.735 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -53.83 142.4 44.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.668 1.587 . . . . 0.0 111.152 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.04 21.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.989 4.459 . . . . 0.0 117.395 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.72 -30.04 70.66 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.582 -1.324 . . . . 0.0 111.743 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.98 155.12 35.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.969 0.507 . . . . 0.0 109.699 172.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.39 41.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.787 1.635 . . . . 0.0 111.206 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.537 ' CG ' HG12 ' A' ' 198' ' ' VAL . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 171' ' ' PHE . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -103.06 90.63 3.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.4 m -50.17 -46.88 54.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.69 1.596 . . . . 0.0 112.259 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.4 m -142.06 150.07 40.77 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.21 105.38 2.48 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.26 67.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.068 0.547 . . . . 0.0 112.182 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.677 1.591 . . . . 0.0 108.071 177.37 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.506 0.193 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.5 17.68 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.469 1.508 . . . . 0.0 114.659 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -129.4 127.77 41.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.266 1.826 . . . . 0.0 107.328 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.84 120.06 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 78' ' ' LEU . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.558 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.447 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 75' ' ' MET . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 159' ' ' VAL . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 124' ' ' LEU . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -79.44 -13.44 59.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -135.4 164.44 27.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.214 2.206 . . . . 0.0 106.869 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.28 -8.18 16.71 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 30.1 tp -75.49 64.98 1.67 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.339 1.856 . . . . 0.0 111.265 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.06 84.6 3.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.913 157.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.44 -12.71 11.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.764 2.31 . . . . 0.0 113.284 171.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -63.84 -27.26 69.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -154.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.12 84.62 1.93 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 110.234 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.3 28.36 15.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.928 1.691 . . . . 0.0 113.55 162.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 118' ' ' LEU . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 118' ' ' LEU . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 224' ' ' LYS . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -130.65 100.52 5.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.6 m -58.93 -32.36 69.51 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.865 0.866 . . . . 0.0 111.698 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 p -138.15 135.87 36.12 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.29 1.836 . . . . 0.0 107.783 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.48 -19.8 45.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -152.4 98.7 2.42 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.736 1.214 . . . . 0.0 108.137 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 172.335 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.942 -0.075 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -77.17 62.09 2.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -162.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.71 165.82 18.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 109.817 155.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.82 97.5 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.416 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -75.84 -23.83 55.77 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -142.25 157.65 44.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.029 2.532 . . . . 0.0 106.637 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 113.2 4.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.8 tp -135.2 139.14 44.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.071 1.348 . . . . 0.0 107.745 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 33.12 62.24 1.53 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.464 2.305 . . . . 0.0 114.387 -171.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.75 -4.32 6.99 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.969 3.113 . . . . 0.0 115.622 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -106.66 -3.83 20.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.022 1.329 . . . . 0.0 112.07 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.69 -112.51 0.33 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.164 0.893 . . . . 0.0 110.352 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.35 -41.5 89.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 111.363 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.465 HG21 HG11 ' A' ' 237' ' ' VAL . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 204' ' ' ILE . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -135.71 98.21 3.86 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.2 m -57.59 149.43 21.5 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.842 0.857 . . . . 0.0 109.192 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -65.84 92.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.754 1.222 . . . . 0.0 109.124 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.88 104.2 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.245 1.018 . . . . 0.0 108.958 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.36 91.88 2.25 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 172.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.074 1.75 . . . . 0.0 108.073 179.096 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.27 35.15 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.669 1.988 . . . . 0.0 114.199 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.85 80.34 1.8 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.111 1.765 . . . . 0.0 107.183 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.11 123.66 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 159' ' ' VAL . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 124' ' ' LEU . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.8 -88.27 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -73.17 -21.56 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.68 89.33 1.76 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -121.3 9.61 10.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 111.974 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -62.98 116.83 27.26 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.432 1.493 . . . . 0.0 110.128 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.63 -20.48 58.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.829 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -66.53 -26.99 67.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.041 0.937 . . . . 0.0 111.533 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.32 143.96 51.85 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.12 9.02 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.511 1.524 . . . . 0.0 113.553 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 118' ' ' LEU . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -77.57 52.34 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.5 t -74.35 -37.49 63.49 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -64.53 128.62 36.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.184 1.394 . . . . 0.0 109.321 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -65.97 -35.87 81.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.681 0.393 . . . . 0.0 111.384 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.28 102.85 3.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.401 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 169.014 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -75.96 62.66 1.64 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.038 1.335 . . . . 0.0 112.75 -176.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -113.73 169.11 9.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.134 1.773 . . . . 0.0 108.348 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 129.51 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 128.33 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.26 -68.72 0.42 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 162.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -71.25 152.62 43.12 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 59.1 tp -146.36 80.23 1.56 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.59 73.03 9.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.455 0.702 . . . . 0.0 110.914 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.92 -8.52 22.83 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.439 2.759 . . . . 0.0 114.882 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.45 -19.52 62.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.315 1.446 . . . . 0.0 113.102 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.36 -171.28 1.73 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.895 1.278 . . . . 0.0 111.975 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.9 2.98 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.211 1.805 . . . . 0.0 113.477 170.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 118' ' ' LEU . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 118' ' ' LEU . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 237' ' ' VAL . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 224' ' ' LYS . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 204' ' ' ILE . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -143.43 93.08 2.44 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 t -67.02 126.73 30.07 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.8 m -141.57 159.0 43.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.58 1.552 . . . . 0.0 107.703 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.46 81.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.038 0.935 . . . . 0.0 112.028 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.2 43.61 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.159 1.384 . . . . 0.0 107.674 176.787 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -11.34 60.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -108.72 153.8 22.94 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.285 . . . . 0.0 109.704 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.01 133.63 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 159' ' ' VAL . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -79.14 -24.85 43.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -136.19 -174.32 3.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.336 2.254 . . . . 0.0 108.242 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.31 25.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.712 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.5 tt 13.81 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 131.224 3.81 . . . . 0.0 114.304 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.61 71.69 1.04 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.925 2.09 . . . . 0.0 112.148 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.65 -37.82 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.313 2.008 . . . . 0.0 112.891 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -92.37 -14.36 28.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.63 1.172 . . . . 0.0 112.519 -166.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.78 -167.8 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.33 1.062 . . . . 0.0 111.408 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.18 -6.27 2.95 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.973 1.309 . . . . 0.0 112.278 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 118' ' ' LEU 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 167' ' ' GLU . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.438 ' CD2' HG22 ' A' ' 237' ' ' VAL . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 171' ' ' PHE . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -78.48 68.36 4.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.3 t -71.21 -39.18 71.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 m -65.85 136.08 55.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.777 1.231 . . . . 0.0 109.469 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.74 166.96 14.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.21 0.604 . . . . 0.0 110.789 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.49 85.32 3.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.173 0.989 . . . . 0.0 109.421 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 167.037 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.27 4.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -135.25 160.09 39.49 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.411 1.884 . . . . 0.0 108.649 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.11 154.41 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -55.76 116.82 3.15 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 46.72 26.26 0.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.651 2.38 . . . . 0.0 115.402 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.4 mmt -129.25 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.952 1.251 . . . . 0.0 111.017 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.2 tp -148.1 107.54 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 127.663 2.385 . . . . 0.0 104.636 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -116.45 94.01 41.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.425 1.09 . . . . 0.0 108.197 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.27 -25.65 73.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.845 2.363 . . . . 0.0 113.718 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -74.95 -16.85 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 112.031 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.83 164.68 16.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.916 0.78 . . . . 0.0 110.438 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -92.07 19.46 6.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.766 1.626 . . . . 0.0 111.671 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -117.18 32.62 6.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.0 m -57.79 -34.41 69.58 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.108 -0.995 . . . . 0.0 110.765 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.3 m -60.51 115.0 3.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.161 1.384 . . . . 0.0 109.796 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.34 62.98 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -105.78 103.68 13.23 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.263 1.425 . . . . 0.0 108.268 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttm 68.87 14.42 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.039 2.136 . . . . 0.0 114.01 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -107.92 172.88 6.58 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.401 1.001 . . . . 0.0 110.659 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.72 133.34 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' CE2' HG22 ' A' ' 178' ' ' VAL . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 102' ' ' LEU . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 90' ' ' TRP . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.435 ' H ' ' HE3' ' A' ' 129' ' ' MET . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -131.83 16.55 4.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -122.18 148.27 45.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.679 1.592 . . . . 0.0 107.592 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 38.78 0.31 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.738 1.615 . . . . 0.0 111.867 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.4 157.08 44.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.887 1.275 . . . . 0.0 109.098 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.34 91.87 2.1 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.032 1.333 . . . . 0.0 109.209 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.58 -71.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.999 2.466 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -104.37 -6.57 20.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.752 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.49 -26.77 66.53 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.018 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.1 33.45 4.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.099 1.76 . . . . 0.0 112.54 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 162' ' ' VAL . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 159' ' ' VAL . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.418 ' CG ' HG21 ' A' ' 178' ' ' VAL . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.543 ' CD1' HG12 ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 198' ' ' VAL . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 21' ' ' TYR . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 174' ' ' VAL . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -78.99 -46.82 17.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.5 m -39.56 107.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.145 2.578 . . . . 0.0 111.931 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.25 41.2 p 52.88 -0.19 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.338 3.055 . . . . 0.0 116.264 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.83 16.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.953 1.301 . . . . 0.0 110.994 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -149.31 162.35 40.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.422 1.089 . . . . 0.0 110.039 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.854 1.662 . . . . 0.0 108.252 178.052 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.993 0.425 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.41 -7.48 32.03 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -78.92 81.74 5.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.38 142.05 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 62' ' ' LEU . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -0.45 10.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -165.71 117.86 1.11 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.463 1.505 . . . . 0.0 107.285 160.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.27 173.29 15.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.764 0.826 . . . . 0.0 111.309 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 52.6 tp -144.08 -52.98 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.401 1.08 . . . . 0.0 109.807 159.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -141.97 81.01 14.9 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.19 -89.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.044 2.496 . . . . 0.0 110.684 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.9 -42.98 13.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.52 -179.21 7.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.256 1.422 . . . . 0.0 110.261 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.41 99.79 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.352 1.861 . . . . 0.0 109.906 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 162' ' ' VAL . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' TRP . . . . . 0.431 ' CD2' HD12 ' A' ' 219' ' ' ILE . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 211' ' ' TRP . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 236' ' ' ILE . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 227' ' ' ILE 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -88.58 119.11 28.74 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 2.3 m -67.33 -31.55 71.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.416 0.553 . . . . 0.0 110.497 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -150.47 167.43 27.18 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.91 1.284 . . . . 0.0 108.571 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.64 115.33 8.76 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.55 133.48 55.87 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 C-N-CA 125.99 1.716 . . . . 0.0 107.587 174.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 135' ' ' THR . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 119' ' ' ILE . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 64' ' ' THR . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 32' ' ' VAL . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 39' ' ' HIS . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 71' ' ' LEU . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt . . . . . 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 122.576 1.179 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.537 ' CG ' HG12 ' A' ' 198' ' ' VAL . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 171' ' ' PHE . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 78' ' ' LEU . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.558 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.447 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 75' ' ' MET . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 159' ' ' VAL . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 124' ' ' LEU . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 118' ' ' LEU . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 118' ' ' LEU . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 224' ' ' LYS . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.416 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt . . . . . 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.465 HG21 HG11 ' A' ' 237' ' ' VAL . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 204' ' ' ILE . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 159' ' ' VAL . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 124' ' ' LEU . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 118' ' ' LEU . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 118' ' ' LEU . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 118' ' ' LEU . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 237' ' ' VAL . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 224' ' ' LYS . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 204' ' ' ILE . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 159' ' ' VAL . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 118' ' ' LEU 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 167' ' ' GLU . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.438 ' CD2' HG22 ' A' ' 237' ' ' VAL . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 171' ' ' PHE . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 . . . . . 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.455 ' CE2' HG22 ' A' ' 178' ' ' VAL . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 102' ' ' LEU . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 90' ' ' TRP . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.435 ' H ' ' HE3' ' A' ' 129' ' ' MET . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 122.767 1.27 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 162' ' ' VAL . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 159' ' ' VAL . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.418 ' CG ' HG21 ' A' ' 178' ' ' VAL . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.543 ' CD1' HG12 ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 198' ' ' VAL . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 21' ' ' TYR . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 174' ' ' VAL . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 62' ' ' LEU . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 162' ' ' VAL . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' TRP . . . . . 0.431 ' CD2' HD12 ' A' ' 219' ' ' ILE . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 211' ' ' TRP . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 236' ' ' ILE . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 227' ' ' ILE 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -89.49 -18.56 26.47 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.046 1.748 . . . . 0.0 113.947 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.75 125.76 33.47 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.69 94.77 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.14 134.59 87.3 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.425 0.69 . . . . 0.0 109.872 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.82 148.75 71.75 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.348 2.032 . . . . 0.0 109.086 168.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.68 -53.04 37.99 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.597 -0.689 . . . . 0.0 110.46 -171.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -142.7 177.41 8.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.371 1.868 . . . . 0.0 108.455 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.6 t -127.08 140.46 52.26 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.639 1.176 . . . . 0.0 108.503 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -95.7 106.12 18.2 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -97.4 132.4 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -129.92 113.05 17.44 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.971 1.308 . . . . 0.0 110.37 -173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.64 106.64 0.93 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.571 2.848 . . . . 0.0 109.681 169.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.03 -40.3 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.288 1.035 . . . . 0.0 109.972 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -65.43 -36.49 84.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.386 0.539 . . . . 0.0 110.806 -172.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -90.22 86.94 6.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.687 0.795 . . . . 0.0 109.503 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.06 38.49 0.09 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.389 1.876 . . . . 0.0 112.878 -175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.27 -43.04 99.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.496 1.119 . . . . 0.0 111.189 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -93.28 141.71 24.34 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.898 1.279 . . . . 0.0 109.024 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.26 162.33 41.93 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.553 2.168 . . . . 0.0 110.951 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -31.33 72.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.573 0.749 . . . . 0.0 110.402 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -54.75 -50.23 68.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.797 0.839 . . . . 0.0 109.983 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.47 89.5 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.687 -0.633 . . . . 0.0 111.371 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -52.36 -57.75 8.81 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.121 0.968 . . . . 0.0 110.042 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -61.33 -45.2 99.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.753 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.47 72.47 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.623 1.556 . . . . 0.0 111.871 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -57.85 -54.2 49.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.754 0.822 . . . . 0.0 110.269 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.25 -41.99 92.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 121.942 -0.474 . . . . 0.0 109.742 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -54.91 -52.38 63.11 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 126.132 1.773 . . . . 0.0 110.42 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -54.16 -44.24 71.29 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.259 0.936 . . . . 0.0 110.953 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.29 -40.36 74.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.024 -177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.62 -34.91 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.893 1.224 . . . . 0.0 111.403 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -60.25 -34.7 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.76 1.163 . . . . 0.0 110.674 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -57.19 -35.44 69.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.016 0.926 . . . . 0.0 111.275 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.34 -36.56 33.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.034 0.933 . . . . 0.0 111.102 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.2 m -62.34 168.41 3.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.702 0.801 . . . . 0.0 111.644 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 m -122.32 157.1 32.51 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.727 1.611 . . . . 0.0 107.393 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.83 165.07 25.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -140.71 151.15 44.28 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 163.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -62.71 132.81 53.51 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.24 1.33 60.04 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 117.624 -1.653 . . . . 0.0 114.971 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.4 mt -114.63 110.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 120.72 2.26 . . . . 0.0 106.319 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -64.72 -41.58 95.86 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 110.159 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -64.24 130.79 94.78 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.161 1.384 . . . . 0.0 109.799 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.18 138.21 71.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.434 2.756 . . . . 0.0 111.876 171.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.1 126.54 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.209 1.404 . . . . 0.0 107.756 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 mp -64.75 162.29 37.84 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 123.243 0.617 . . . . 0.0 111.456 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.75 163.6 35.38 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.097 2.531 . . . . 0.0 111.375 166.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.29 162.7 11.45 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -73.75 102.42 3.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.966 0.906 . . . . 0.0 111.732 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -80.73 140.52 35.51 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 161.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -78.14 -33.96 50.13 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.047 -0.408 . . . . 0.0 110.678 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.06 83.8 64.91 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.658 1.583 . . . . 0.0 108.421 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.67 -175.96 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.679 2.919 . . . . 0.0 112.5 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -62.49 -48.84 77.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.56 0.744 . . . . 0.0 110.113 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 pp -154.07 172.98 16.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.93 1.292 . . . . 0.0 109.754 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -143.47 170.03 16.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 108.996 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.5 109.57 20.71 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -104.57 126.36 51.58 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.4 m -133.46 143.09 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.81 118.2 25.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.081 0.952 . . . . 0.0 108.829 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.74 118.75 31.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.59 122.7 44.32 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 135' ' ' THR . 31.0 p -101.57 -168.92 1.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.302 1.041 . . . . 0.0 109.597 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -51.11 -39.54 56.41 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.148 1.379 . . . . 0.0 111.892 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -126.25 -19.19 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -165.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -138.92 161.98 35.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.323 0.965 . . . . 0.0 111.077 -164.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.5 m -137.11 134.28 36.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.6 pt -132.39 135.57 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.27 141.62 34.82 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 171.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.6 139.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.798 1.639 . . . . 0.0 106.793 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.0 112.6 24.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.958 1.303 . . . . 0.0 108.051 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.9 mm -107.09 106.8 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -69.62 120.31 15.2 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -54.49 -31.96 56.97 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.036 0.835 . . . . 0.0 112.024 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.24 -24.73 62.24 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.743 1.617 . . . . 0.0 112.332 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -117.06 -20.27 9.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.172 0.989 . . . . 0.0 111.15 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt 41.06 42.65 1.64 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.5 2.32 . . . . 0.0 111.714 -162.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -109.32 148.07 31.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tt -78.49 91.83 4.58 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.13 -33.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.829 0.286 . . . . 0.0 110.986 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.32 -179.82 39.91 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 118.613 0.642 . . . . 0.0 112.853 -175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -144.86 158.22 43.87 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.564 1.545 . . . . 0.0 108.701 -160.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -124.24 118.27 26.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.51 1.124 . . . . 0.0 108.679 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 m -73.65 143.61 82.2 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.79 -12.77 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.368 2.045 . . . . 0.0 113.798 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.99 -5.62 33.87 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.502 1.048 . . . . 0.0 113.773 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.37 19.12 39.59 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.159 1.48 . . . . 0.0 113.219 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.95 160.67 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 118.267 1.033 . . . . 0.0 108.9 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -115.1 159.7 20.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.64 0.776 . . . . 0.0 109.455 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -131.69 159.24 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.0 108.426 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -140.51 146.4 38.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 108.279 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -68.33 128.02 35.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.86 -178.25 19.31 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.76 138.84 26.04 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.076 1.35 . . . . 0.0 107.361 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t70 48.11 41.05 14.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.457 1.503 . . . . 0.0 112.074 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.86 91.09 0.09 OUTLIER Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -97.45 167.77 10.79 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.075 1.35 . . . . 0.0 110.819 174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 m -132.38 140.82 48.64 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.526 1.93 . . . . 0.0 108.325 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -74.01 21.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.286 1.434 . . . . 0.0 113.056 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.08 -44.36 54.36 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.593 1.157 . . . . 0.0 109.641 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.15 23.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.994 1.717 . . . . 0.0 112.043 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -128.47 8.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -61.61 159.4 13.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.947 0.499 . . . . 0.0 110.503 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -54.65 118.26 16.27 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.289 0.636 . . . . 0.0 111.38 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.05 165.51 32.38 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.472 2.114 . . . . 0.0 111.318 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -74.66 170.39 15.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.75 1.22 . . . . 0.0 108.916 164.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -110.84 132.9 53.81 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 121.379 -0.825 . . . . 0.0 109.39 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.64 -17.09 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.44 53.62 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.806 1.193 . . . . 0.0 113.825 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -136.09 175.49 9.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.407 1.483 . . . . 0.0 109.865 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -151.73 11.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.428 1.489 . . . . 0.0 110.338 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -137.4 60.88 0.6 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 118.77 1.285 . . . . 0.0 112.105 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 173.26 14.26 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.65 1.225 . . . . 0.0 112.451 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -58.63 -30.39 67.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.816 1.246 . . . . 0.0 112.517 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -59.84 -27.01 66.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 111.541 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.77 -49.91 34.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 119' ' ' ILE . 19.7 mt -79.13 -50.59 10.77 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -166.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -131.27 -32.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.23 -76.96 0.88 Allowed Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.684 1.129 . . . . 0.0 112.174 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -73.57 -52.13 14.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.313 1.045 . . . . 0.0 111.174 -171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -69.82 163.73 25.19 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.55 169.18 35.45 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -76.9 -13.22 60.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.374 -0.486 . . . . 0.0 111.818 166.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -17.94 64.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -164.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -16.96 64.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.963 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.22 124.13 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 119.991 1.269 . . . . 0.0 109.378 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.43 143.72 54.95 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.9 mtm -117.04 138.87 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.539 1.936 . . . . 0.0 106.275 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.86 173.09 40.42 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -54.31 -43.91 71.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.547 1.174 . . . . 0.0 111.772 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.59 76.06 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.42 0.688 . . . . 0.0 109.38 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -70.12 -31.68 69.34 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.341 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 55.8 mtp -63.8 -54.17 39.4 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.756 1.162 . . . . 0.0 109.933 170.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 64' ' ' THR . 60.0 m -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.214 0.915 . . . . 0.0 110.893 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -52.42 -51.0 61.44 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.735 0.814 . . . . 0.0 110.478 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.55 83.01 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.701 0.682 . . . . 0.0 110.908 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.74 -45.08 94.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.349 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.82 -49.52 77.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.588 1.085 . . . . 0.0 109.674 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.34 -26.01 67.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.309 1.444 . . . . 0.0 112.071 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.43 -35.45 21.27 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.656 0.782 . . . . 0.0 111.279 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.87 77.6 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.34 -0.85 . . . . 0.0 112.026 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -68.79 -8.0 39.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -64.22 154.84 33.73 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.659 1.118 . . . . 0.0 110.538 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -138.28 -176.69 4.54 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.829 2.451 . . . . 0.0 106.448 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -52.7 -32.34 42.24 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 25.6 mmt -125.59 140.58 52.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.059 1.744 . . . . 0.0 107.477 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.6 tp -157.72 149.43 21.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.185 1.394 . . . . 0.0 107.95 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -78.43 -52.03 1.46 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.84 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -75.91 59.53 5.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.873 2.382 . . . . 0.0 114.004 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -51.71 67.45 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.432 -1.418 . . . . 0.0 111.387 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.19 75.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.667 0.667 . . . . 0.0 111.696 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -71.21 -50.34 34.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.677 0.791 . . . . 0.0 109.528 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.9 p -60.41 -36.77 78.93 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.574 -0.704 . . . . 0.0 109.996 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -60.97 -47.87 84.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.619 -1.182 . . . . 0.0 111.396 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.9 p -62.4 -38.62 90.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.614 2.006 . . . . 0.0 111.018 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -57.0 -47.97 79.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.48 -0.763 . . . . 0.0 111.594 173.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.251 2.8 pp -68.84 -27.48 65.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.433 1.469 . . . . 0.0 112.606 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.59 -44.39 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 120.107 1.321 . . . . 0.0 110.279 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -65.7 -38.8 90.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.8 1.182 . . . . 0.0 111.609 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.55 -46.46 89.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.172 -0.955 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.8 -42.07 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 120.198 1.363 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.4 p -66.17 -36.05 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 110.918 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 98.8 mtp -72.39 -54.71 8.61 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.832 -0.543 . . . . 0.0 110.562 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.8 -68.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.535 1.134 . . . . 0.0 109.485 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.67 -50.15 46.75 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.314 0.645 . . . . 0.0 109.727 -165.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -64.17 -33.68 76.35 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.54 -38.52 35.44 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.105 1.336 . . . . 0.0 113.567 172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.9 tp -65.3 -32.31 73.9 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.22 . . . . 0.0 111.796 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -93.38 -16.42 24.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.126 -0.94 . . . . 0.0 112.674 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 68.5 m-85 -133.43 102.23 5.45 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.934 1.294 . . . . 0.0 111.097 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -54.85 -33.88 62.27 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.066 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.1 t -57.52 -56.18 25.19 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.625 1.102 . . . . 0.0 111.292 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.65 -31.07 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.257 -1.527 . . . . 0.0 109.686 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t -53.05 -59.67 4.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.946 0.794 . . . . 0.0 110.074 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -66.43 -30.84 71.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.667 1.121 . . . . 0.0 112.764 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.2 m -59.72 -53.17 61.11 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.05 -35.4 74.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.755 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.9 -48.99 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 120.284 1.402 . . . . 0.0 111.549 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.71 71.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.664 0.386 . . . . 0.0 111.891 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.09 -36.62 7.55 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.584 0.611 . . . . 0.0 114.112 -168.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.32 -45.63 90.79 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.321 1.448 . . . . 0.0 110.213 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.09 -17.75 61.97 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.182 0.593 . . . . 0.0 112.489 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.1 t -69.39 156.24 39.14 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.493 1.042 . . . . 0.0 110.375 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -79.45 -34.71 41.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.383 0.673 . . . . 0.0 111.371 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -81.51 -16.98 50.15 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.386 0.539 . . . . 0.0 111.755 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.84 -163.68 54.33 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 158.82 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.055 1.342 . . . . 0.0 108.253 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.6 m -122.39 128.23 50.69 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.4 pt? -75.81 -176.48 3.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.274 0.63 . . . . 0.0 110.97 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.0 t -125.71 164.65 20.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.031 1.333 . . . . 0.0 108.938 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.1 m -55.02 -42.63 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.0 m -56.04 -53.64 54.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.033 1.733 . . . . 0.0 109.207 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -63.81 -51.08 66.38 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.716 0.806 . . . . 0.0 109.53 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.23 43.66 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 123.775 0.702 . . . . 0.0 112.321 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.33 -43.74 55.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 117.922 0.861 . . . . 0.0 111.52 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.19 -35.68 81.83 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.132 0.878 . . . . 0.0 112.005 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 34.0 m -67.81 -51.43 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.642 0.655 . . . . 0.0 110.156 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.23 -28.79 69.61 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.906 -0.497 . . . . 0.0 112.119 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -93.78 51.71 1.59 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.649 0.658 . . . . 0.0 110.211 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -58.91 -21.43 57.76 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.167 1.387 . . . . 0.0 113.016 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -55.99 -38.53 70.57 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.137 -0.977 . . . . 0.0 111.495 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -64.57 -39.34 93.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.614 1.166 . . . . 0.0 110.523 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.46 -51.42 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 51.2 m -65.44 -25.92 67.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -78.01 -41.86 34.44 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.335 1.425 . . . . 0.0 111.06 167.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.14 77.59 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.012 0.824 . . . . 0.0 110.977 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.33 -41.04 79.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.66 0.784 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -70.04 -42.32 73.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.865 0.466 . . . . 0.0 111.529 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -63.67 -34.24 77.42 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.102 -0.999 . . . . 0.0 110.691 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -73.6 -4.52 34.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.688 1.195 . . . . 0.0 114.048 170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.94 -62.83 1.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.227 1.376 . . . . 0.0 109.755 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.72 -26.59 57.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -114.45 96.23 42.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.291 1.436 . . . . 0.0 108.916 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.79 -10.45 26.42 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.122 2.548 . . . . 0.0 114.346 -170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 5.0 t -130.19 21.97 5.26 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.316 1.047 . . . . 0.0 110.668 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.88 161.94 9.69 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 121.219 -0.925 . . . . 0.0 110.445 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 131.88 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 170.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.3 mt -121.15 109.0 35.65 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.13 -28.48 79.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.989 1.793 . . . . 0.0 111.747 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -57.25 -44.54 83.97 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.068 0.947 . . . . 0.0 110.451 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 15.8 tpp -95.18 -27.71 15.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.2 1.0 . . . . 0.0 111.11 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -57.1 -29.45 63.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.781 1.232 . . . . 0.0 111.684 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -57.27 -31.68 65.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.539 1.063 . . . . 0.0 112.282 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.82 4.4 41.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.767 0.827 . . . . 0.0 111.298 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 83.77 4.45 88.83 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.722 1.153 . . . . 0.0 112.509 -171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.1 mt -96.51 81.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -85.59 -10.71 55.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -127.92 143.27 51.1 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.403 1.081 . . . . 0.0 109.018 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.3 -31.01 70.84 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.9 -0.5 . . . . 0.0 112.311 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -61.28 -44.25 97.54 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.374 0.67 . . . . 0.0 109.979 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -64.37 -41.84 96.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.373 0.669 . . . . 0.0 109.571 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.74 -52.56 65.19 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.769 -0.582 . . . . 0.0 110.344 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.41 73.55 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.001 0.92 . . . . 0.0 112.911 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -82.31 -6.84 59.52 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.5 mt -99.62 -41.57 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.175 1.39 . . . . 0.0 109.489 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.5 m -97.07 -175.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -138.09 -39.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.733 0.813 . . . . 0.0 111.947 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.2 mt -137.98 157.19 46.89 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.4 m -134.69 149.35 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.695 1.134 . . . . 0.0 110.145 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -61.39 161.59 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.668 0.787 . . . . 0.0 109.411 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -62.69 106.67 0.83 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -101.57 118.33 36.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.1 t -62.73 147.68 48.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.7 m -79.89 79.09 6.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.588 0.755 . . . . 0.0 109.151 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -79.61 -99.69 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.06 0.944 . . . . 0.0 108.848 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -148.89 152.79 37.04 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 108.418 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.353 1.461 . . . . 0.0 107.919 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 62.38 0.6 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.189 1.396 . . . . 0.0 109.135 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -137.75 100.77 4.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.246 1.418 . . . . 0.0 107.218 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.94 101.46 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 163.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.39 116.23 61.57 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.12 125.07 16.29 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.933 2.422 . . . . 0.0 111.673 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -65.61 -55.58 16.84 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.95 102.45 3.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 107.734 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -70.84 98.41 1.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -67.46 148.25 51.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -128.74 140.46 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -128.41 96.17 31.29 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 125.236 1.414 . . . . 0.0 108.322 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -62.86 112.96 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.573 2.182 . . . . 0.0 109.486 171.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.0 -46.47 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.483 1.113 . . . . 0.0 109.594 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.08 -20.55 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -83.64 73.4 10.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.081 0.855 . . . . 0.0 109.317 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 75.33 0.87 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.728 1.211 . . . . 0.0 109.119 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.48 -81.44 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.481 1.512 . . . . 0.0 109.325 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -71.16 129.1 89.65 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -83.88 172.9 9.59 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.712 2.275 . . . . 0.0 111.086 -173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.59 -38.76 75.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.413 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 m -53.47 -40.09 65.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 120.206 1.366 . . . . 0.0 112.14 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.77 -49.6 74.36 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.902 0.774 . . . . 0.0 110.65 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -63.62 -51.49 65.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.082 0.553 . . . . 0.0 110.501 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.62 -44.48 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.2 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.36 87.99 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.993 1.27 . . . . 0.0 111.369 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -57.62 -49.66 75.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.266 0.627 . . . . 0.0 110.365 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.71 -35.83 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.457 -0.777 . . . . 0.0 110.539 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HA ' HG12 ' A' ' 32' ' ' VAL . 51.1 ttt180 -60.87 -32.44 71.87 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.058 . . . . 0.0 111.577 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -53.47 -51.8 61.57 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.253 0.933 . . . . 0.0 109.913 173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.27 -37.7 69.0 Favored 'General case' 0 N--CA 1.461 0.111 0 O-C-N 122.049 -0.407 . . . . 0.0 112.002 -174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -67.97 -30.86 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 O-C-N 121.34 -0.85 . . . . 0.0 110.402 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.07 -46.37 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 118.87 0.759 . . . . 0.0 109.113 170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -50.71 -45.18 58.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.47 1.032 . . . . 0.0 110.328 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -90.03 10.7 23.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.655 1.182 . . . . 0.0 113.699 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.8 176.55 6.95 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.695 1.589 . . . . 0.0 111.693 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 m -134.73 155.48 50.5 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.281 2.232 . . . . 0.0 107.414 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.29 156.6 28.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.554 0.742 . . . . 0.0 110.494 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' HB2' HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -153.02 95.52 1.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 168.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -59.71 122.25 13.67 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.474 0.71 . . . . 0.0 110.511 -159.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.78 -17.11 30.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.56 1.552 . . . . 0.0 112.778 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.87 127.85 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.05 -45.06 67.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.12 0.568 . . . . 0.0 110.163 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.34 141.91 97.82 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.528 1.931 . . . . 0.0 110.135 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.52 155.56 41.27 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.975 2.45 . . . . 0.0 112.501 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 39' ' ' HIS . 11.8 t -131.67 158.72 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.938 1.295 . . . . 0.0 108.534 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.0 mt -86.31 162.01 47.17 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 49.5 Cg_exo -60.79 158.81 31.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.032 3.155 . . . . 0.0 113.879 166.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 35.0 Cg_exo -65.88 31.92 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.489 1 C-N-CA 126.053 4.502 . . . . 0.0 116.636 168.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.315 7.8 pt-20 53.02 106.72 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.239 3.016 . . . . 0.0 116.905 -176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -66.25 175.05 2.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.9 2.08 . . . . 0.0 111.029 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -131.55 9.6 4.69 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.046 1.338 . . . . 0.0 113.24 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 m -130.65 91.43 37.57 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.724 1.21 . . . . 0.0 108.172 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.22 61.6 8.2 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.872 3.048 . . . . 0.0 111.536 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -72.56 -26.37 61.7 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.56 133.05 52.44 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.266 1.426 . . . . 0.0 107.483 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.34 175.09 13.78 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.681 1.592 . . . . 0.0 108.667 167.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.4 110.1 18.89 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -128.29 109.29 11.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.8 m -132.6 149.96 52.23 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.482 1.113 . . . . 0.0 108.159 -164.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -121.53 117.11 25.99 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-N 119.557 1.071 . . . . 0.0 110.806 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.01 141.39 37.5 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 166.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -136.34 139.64 42.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.524 0.73 . . . . 0.0 110.45 -169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.31 173.41 14.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.068 2.147 . . . . 0.0 107.097 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -37.22 -56.35 0.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.274 2.229 . . . . 0.0 113.36 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.1 p -124.61 14.89 8.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.246 1.418 . . . . 0.0 111.091 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -126.62 124.8 40.73 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.775 0.83 . . . . 0.0 109.099 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -137.18 140.26 41.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.94 123.96 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 162.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.77 100.28 12.4 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 169.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 71' ' ' LEU . 2.6 pt? -86.87 146.77 26.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.42 1.464 . . . . 0.0 109.657 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.9 26.79 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.603 1.561 . . . . 0.0 107.897 -174.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -104.37 118.85 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -71.74 99.22 2.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -55.88 -26.76 48.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.032 0.833 . . . . 0.0 112.436 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -56.65 -34.47 67.35 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 125.944 1.698 . . . . 0.0 112.632 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.26 1.33 5.15 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.065 0.946 . . . . 0.0 111.485 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.0 mt 30.45 71.26 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.079 2.951 . . . . 0.0 112.398 -163.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -128.92 148.24 50.91 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tt -76.4 87.8 3.17 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.42 -26.44 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 118.782 -0.627 . . . . 0.0 111.517 -175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.16 174.23 45.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.675 1.125 . . . . 0.0 112.43 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -149.39 167.61 25.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.428 0.691 . . . . 0.0 110.029 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -121.95 126.54 48.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 106.35 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -103.8 168.2 8.99 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 119.452 1.024 . . . . 0.0 110.671 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -17.0 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.308 3.339 . . . . 0.0 114.886 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.05 -12.33 57.31 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.323 173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.92 45.33 10.61 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 118.714 1.257 . . . . 0.0 110.625 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.45 159.07 15.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.321 1.448 . . . . 0.0 107.108 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -113.48 148.28 36.27 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.089 0.956 . . . . 0.0 109.19 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -119.05 154.18 33.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.273 1.429 . . . . 0.0 108.535 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -135.95 138.67 42.56 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.411 0.685 . . . . 0.0 109.909 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -69.46 107.11 3.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.975 1.71 . . . . 0.0 108.246 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.94 -175.64 39.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -143.7 136.6 27.48 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.512 1.125 . . . . 0.0 108.094 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t0 38.67 55.28 1.94 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.947 2.099 . . . . 0.0 112.445 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.59 46.95 0.14 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.73 150.53 48.96 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.678 0.791 . . . . 0.0 109.031 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.3 p -127.54 161.85 27.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.51 0.724 . . . . 0.0 109.397 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -76.92 15.47 0.67 Allowed 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.186 -0.946 . . . . 0.0 113.175 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.85 -53.11 61.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.249 1.42 . . . . 0.0 110.213 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.34 64.57 4.27 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.458 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.36 -62.7 3.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.971 1.272 . . . . 0.0 112.191 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -133.27 -151.72 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.68 2.392 . . . . 0.0 106.052 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.43 120.03 61.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 120.465 1.484 . . . . 0.0 109.388 163.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.15 -176.67 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.73 2.287 . . . . 0.0 110.379 163.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -110.72 144.98 38.84 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 163.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -74.28 150.07 40.41 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.805 -0.559 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.2 mt -72.64 -32.47 65.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.199 0.599 . . . . 0.0 110.682 166.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.69 -19.67 43.43 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.203 1.382 . . . . 0.0 113.24 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -146.42 105.5 3.89 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.647 1.179 . . . . 0.0 108.014 -173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.99 168.38 28.2 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.93 -85.08 0.16 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 117.266 0.533 . . . . 0.0 113.35 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.9 177.96 7.83 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.861 1.264 . . . . 0.0 110.319 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -49.19 -36.35 19.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.035 1.334 . . . . 0.0 113.915 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -61.06 -43.96 98.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.695 0.798 . . . . 0.0 111.471 175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.21 -37.78 78.26 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.866 0.866 . . . . 0.0 110.772 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.61 -64.77 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.612 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.42 -18.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.57 -83.7 0.33 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 111.265 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -113.72 10.88 17.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.927 0.891 . . . . 0.0 112.189 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -137.1 174.35 10.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.775 1.63 . . . . 0.0 108.144 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.46 -29.64 1.75 Allowed Glycine 0 N--CA 1.464 0.52 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.421 160.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.42 -34.33 14.89 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 117.87 0.835 . . . . 0.0 110.354 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -21.0 22.92 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.383 1.073 . . . . 0.0 111.199 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.4 p -79.29 -14.48 58.99 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.896 0.771 . . . . 0.0 113.008 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.8 m -80.9 84.36 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.619 1.1 . . . . 0.0 111.188 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -62.15 150.89 37.4 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 157.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.1 mtm -141.91 119.12 11.41 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.552 1.941 . . . . 0.0 107.537 -171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.88 172.37 43.12 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.77 -51.02 67.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.068 1.434 . . . . 0.0 111.929 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.07 -44.36 89.18 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.322 0.649 . . . . 0.0 109.387 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -58.4 -49.02 78.78 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.136 0.974 . . . . 0.0 109.822 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.88 -45.83 84.34 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.952 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.0 m -56.49 -50.7 71.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.094 0.958 . . . . 0.0 110.673 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -56.84 -48.02 79.01 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.875 0.761 . . . . 0.0 109.841 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.95 63.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.993 0.517 . . . . 0.0 111.996 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.65 -40.96 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.205 0.457 . . . . 0.0 110.31 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -64.15 -40.91 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.891 0.769 . . . . 0.0 111.386 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.91 -42.33 98.97 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.279 0.632 . . . . 0.0 111.472 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.47 -38.3 74.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.805 0.275 . . . . 0.0 110.973 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.62 -30.22 70.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -71.28 -8.17 51.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.181 1.355 . . . . 0.0 113.336 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -76.04 75.81 2.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.164 1.347 . . . . 0.0 110.267 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -72.6 -21.55 61.11 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.551 -0.718 . . . . 0.0 111.489 165.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -143.52 159.31 42.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.001 1.721 . . . . 0.0 107.83 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 18.3 mmt -86.04 96.15 9.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.384 1.073 . . . . 0.0 109.368 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 19.4 tp -72.36 170.87 13.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.812 0.845 . . . . 0.0 109.735 169.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -53.83 142.4 44.29 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.668 1.587 . . . . 0.0 111.152 176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.04 21.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.989 4.459 . . . . 0.0 117.395 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.72 -30.04 70.66 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.582 -1.324 . . . . 0.0 111.743 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.98 155.12 35.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.969 0.507 . . . . 0.0 109.699 172.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.39 41.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.787 1.635 . . . . 0.0 111.206 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 p -63.68 -33.07 74.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.654 1.581 . . . . 0.0 111.555 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -60.14 -53.22 60.34 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.131 -0.98 . . . . 0.0 110.525 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.9 m -55.9 -31.96 63.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.413 . . . . 0.0 111.179 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -60.12 2.79 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.549 -0.719 . . . . 0.0 111.698 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . 0.25 3.5 pp -63.76 -28.99 70.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.894 1.224 . . . . 0.0 112.927 -169.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.11 -39.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 119.412 1.005 . . . . 0.0 110.434 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -56.99 -48.97 77.16 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.036 0.934 . . . . 0.0 110.014 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.14 -55.13 17.93 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.521 0.6 . . . . 0.0 110.372 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 -39.88 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.214 -170.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.06 -61.37 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.7 ttp -57.0 -40.3 76.34 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.937 0.895 . . . . 0.0 112.383 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 -57.92 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.871 0.469 . . . . 0.0 109.836 -170.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.69 -49.47 53.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.037 0.835 . . . . 0.0 110.624 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -66.78 -25.02 66.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.972 0.806 . . . . 0.0 110.178 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.97 -18.32 32.96 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.299 -1.278 . . . . 0.0 114.333 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.1 tp -78.68 -29.43 45.61 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.762 2.281 . . . . 0.0 111.346 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -95.3 -24.93 16.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.211 1.004 . . . . 0.0 112.908 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.537 ' CG ' HG12 ' A' ' 198' ' ' VAL . 49.7 m-85 -127.75 104.62 7.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.044 1.293 . . . . 0.0 109.902 -166.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.43 -15.6 62.85 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 117.922 -1.037 . . . . 0.0 113.086 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.8 t -58.66 -43.79 89.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.988 1.267 . . . . 0.0 110.175 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.69 -51.0 45.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.73 -54.28 30.1 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 119.368 0.985 . . . . 0.0 110.642 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.61 -39.33 88.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.14 0.882 . . . . 0.0 112.645 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 t -69.0 -43.69 74.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.042 0.837 . . . . 0.0 109.458 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.5 t -66.42 -42.07 89.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 121.531 -0.731 . . . . 0.0 109.404 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -54.84 -51.43 65.9 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.441 1.496 . . . . 0.0 111.463 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.69 -45.93 64.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.689 0.396 . . . . 0.0 111.0 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.36 -23.78 77.67 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.78 -1.011 . . . . 0.0 114.099 -167.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.42 -41.33 76.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.017 1.408 . . . . 0.0 111.935 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.38 -19.64 66.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.376 0.671 . . . . 0.0 112.526 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 45.0 t -70.45 131.96 44.86 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.172 0.896 . . . . 0.0 109.094 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -63.87 -34.92 79.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.053 0.541 . . . . 0.0 110.905 169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.15 -32.2 44.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.335 0.654 . . . . 0.0 110.763 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.27 -174.87 54.61 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.1 0.857 . . . . 0.0 112.068 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.56 168.76 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 127.027 2.131 . . . . 0.0 108.314 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.2 m -136.38 155.76 49.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.1 pp -114.6 168.03 10.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.224 1.01 . . . . 0.0 109.638 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.7 t -110.58 169.12 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.238 0.615 . . . . 0.0 110.045 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.1 m -56.92 -33.32 41.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 124.674 1.19 . . . . 0.0 111.566 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.8 m -56.75 -50.78 71.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.649 1.18 . . . . 0.0 110.348 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -65.61 -46.93 77.4 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 123.404 0.682 . . . . 0.0 109.311 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.86 -50.93 48.3 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 122.039 -0.413 . . . . 0.0 112.118 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -57.64 -54.0 51.83 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.374 1.07 . . . . 0.0 110.538 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -65.15 -35.5 81.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.829 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 171' ' ' PHE . 11.4 m -72.4 -38.69 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.464 1.029 . . . . 0.0 111.424 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -64.64 -53.72 43.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.721 0.808 . . . . 0.0 110.116 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -97.23 68.38 2.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.656 0.662 . . . . 0.0 109.22 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -56.6 -29.39 62.05 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.817 1.247 . . . . 0.0 111.042 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -32.38 62.23 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.028 1.731 . . . . 0.0 112.981 175.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -72.24 -44.5 62.77 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.496 -0.753 . . . . 0.0 109.416 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.1 tp -75.54 -28.18 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 89.5 p -66.85 -47.57 71.54 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.34 1.427 . . . . 0.0 110.575 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -35.66 79.65 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.164 0.893 . . . . 0.0 111.249 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.73 -47.56 80.57 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 118.618 0.644 . . . . 0.0 110.08 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.12 91.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.509 0.724 . . . . 0.0 111.683 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.32 -46.35 90.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.758 0.823 . . . . 0.0 110.47 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.32 -43.83 97.91 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.765 -0.584 . . . . 0.0 110.171 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -65.76 -23.58 66.76 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.406 -0.808 . . . . 0.0 113.11 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.78 -26.36 66.92 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.702 1.137 . . . . 0.0 110.75 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.15 -45.5 9.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.422 1.089 . . . . 0.0 111.281 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -133.22 91.57 27.35 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.293 1.437 . . . . 0.0 109.779 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.05 -12.2 31.89 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.862 2.374 . . . . 0.0 114.68 -171.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.3 t -108.77 4.58 23.82 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.46 1.104 . . . . 0.0 111.443 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.8 111.59 3.32 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.072 -1.018 . . . . 0.0 108.589 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.8 131.99 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 102.93 54.5 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -39.74 70.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.567 2.845 . . . . 0.0 113.764 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 -44.18 77.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.56 1.144 . . . . 0.0 110.169 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 31.1 tpp -85.7 -19.92 30.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.337 0.655 . . . . 0.0 111.599 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -58.76 -34.55 71.55 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.543 -0.723 . . . . 0.0 110.97 169.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -61.61 -33.45 73.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.982 0.81 . . . . 0.0 110.968 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.39 4.97 28.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.65 1.18 . . . . 0.0 111.803 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.46 7.97 88.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.572 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.18 98.39 6.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 CA-C-N 119.282 1.541 . . . . 0.0 107.036 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -83.5 -19.34 35.94 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.476 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.71 173.0 16.07 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.088 1.313 . . . . 0.0 111.457 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.75 -37.27 86.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.06 0.944 . . . . 0.0 112.795 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.74 -39.25 67.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.584 1.084 . . . . 0.0 108.821 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.22 -39.48 75.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.688 0.795 . . . . 0.0 109.731 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.52 66.88 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.789 -0.569 . . . . 0.0 110.798 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.023 0.929 . . . . 0.0 112.474 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -75.89 -10.11 59.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 45.4 mt -107.81 -44.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.549 1.14 . . . . 0.0 110.993 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.62 136.97 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 120.28 1.4 . . . . 0.0 109.85 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -81.56 -42.64 19.84 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.464 1.106 . . . . 0.0 110.61 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -136.61 167.92 20.48 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.13 151.54 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.408 0.683 . . . . 0.0 110.0 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -65.61 152.74 43.44 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -76.78 98.37 4.79 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -103.06 90.63 3.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.4 m -50.17 -46.88 54.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.69 1.596 . . . . 0.0 112.259 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.4 m -142.06 150.07 40.77 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.21 105.38 2.48 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.26 67.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.068 0.547 . . . . 0.0 112.182 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.677 1.591 . . . . 0.0 108.071 177.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.506 0.193 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -72.5 17.68 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.469 1.508 . . . . 0.0 114.659 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.2 mtp85 -129.4 127.77 41.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.266 1.826 . . . . 0.0 107.328 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.84 120.06 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.58 126.6 73.16 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 130.83 39.79 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.91 2.407 . . . . 0.0 111.15 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.28 -59.77 2.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -155.52 -176.9 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.398 1.479 . . . . 0.0 108.423 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -132.36 124.99 29.8 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -84.35 122.26 28.67 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -114.79 130.6 68.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.54 152.61 75.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.705 0.802 . . . . 0.0 111.042 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.04 175.79 9.32 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.379 2.719 . . . . 0.0 111.638 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.17 -66.28 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.774 0.83 . . . . 0.0 109.867 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.16 -22.45 63.92 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.983 0.913 . . . . 0.0 111.96 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.57 30.83 3.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.272 1.429 . . . . 0.0 111.189 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 73.11 0.5 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.548 1.139 . . . . 0.0 110.279 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -69.0 -39.72 79.18 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.639 0.776 . . . . 0.0 109.816 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.58 150.55 97.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.885 1.274 . . . . 0.0 110.179 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.56 147.77 93.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.246 2.63 . . . . 0.0 112.111 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -65.76 -30.35 71.0 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.453 -0.78 . . . . 0.0 110.523 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.9 t -54.53 -43.55 72.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.826 0.851 . . . . 0.0 110.267 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.33 98.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.556 0.617 . . . . 0.0 110.925 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -56.57 -57.12 13.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.265 0.626 . . . . 0.0 110.108 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.82 -47.96 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.096 0.558 . . . . 0.0 109.67 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.99 82.43 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.807 0.843 . . . . 0.0 111.273 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -56.36 -57.91 10.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.814 0.845 . . . . 0.0 110.548 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.19 -36.55 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 121.577 -0.702 . . . . 0.0 110.782 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -63.47 -45.26 91.6 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.026 -1.046 . . . . 0.0 110.951 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.57 -33.73 68.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.903 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.84 -50.92 37.94 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.689 0.677 . . . . 0.0 110.366 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 78' ' ' LEU . 1.7 p -65.44 -20.29 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.805 -1.184 . . . . 0.0 112.53 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 68.8 mt -59.72 -22.49 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.689 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -65.75 -19.96 66.09 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.71 -1.244 . . . . 0.0 112.392 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -115.81 -24.9 7.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.465 1.106 . . . . 0.0 113.528 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 33' ' ' ILE . 16.4 p -75.98 -178.98 4.62 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.081 1.309 . . . . 0.0 111.038 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -131.76 -179.64 5.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.514 1.525 . . . . 0.0 107.054 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -133.35 141.82 48.11 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 120.067 -1.645 . . . . 0.0 108.32 167.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -100.64 113.01 25.49 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.78 124.21 19.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.21 -15.3 18.31 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.027 1.299 . . . . 0.0 111.92 -167.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.86 128.44 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.74 -54.26 24.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.972 0.509 . . . . 0.0 109.923 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -65.46 150.46 95.89 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 122.894 0.477 . . . . 0.0 110.968 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.34 169.11 16.12 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.013 2.475 . . . . 0.0 112.608 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 t -134.97 145.83 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.625 1.97 . . . . 0.0 106.688 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.29 152.02 90.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.36 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.45 164.21 11.41 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.115 2.543 . . . . 0.0 112.373 170.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.05 140.1 82.43 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.372 2.048 . . . . 0.0 109.782 167.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.45 135.13 47.04 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.913 0.885 . . . . 0.0 111.158 -166.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -105.18 179.19 4.34 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.226 1.81 . . . . 0.0 108.581 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -123.7 26.44 7.72 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.256 -0.903 . . . . 0.0 111.204 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.8 81.25 28.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.741 1.616 . . . . 0.0 108.59 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.38 157.52 30.73 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.83 2.354 . . . . 0.0 112.808 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -103.45 -52.12 3.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.154 0.982 . . . . 0.0 108.555 169.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.92 168.54 19.56 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 125.69 1.596 . . . . 0.0 108.996 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.558 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 1.4 p-90 -155.55 171.58 19.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.192 1.397 . . . . 0.0 108.649 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.45 94.68 6.55 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -162.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -76.6 121.1 22.71 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -129.47 120.74 25.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.37 123.71 50.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.228 1.011 . . . . 0.0 108.595 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.88 119.58 38.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 168.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -107.5 111.41 23.68 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.663 1.985 . . . . 0.0 106.994 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -77.32 173.27 12.11 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 161.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -53.96 -47.37 71.39 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.715 -1.241 . . . . 0.0 109.236 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.41 -46.86 59.12 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.271 1.428 . . . . 0.0 112.369 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -149.77 171.15 17.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.303 0.956 . . . . 0.0 112.358 -159.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -142.98 149.42 38.31 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.958 0.903 . . . . 0.0 109.429 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.28 140.21 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.991 1.317 . . . . 0.0 108.156 169.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.89 102.15 12.22 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -80.15 150.94 30.02 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 169.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -128.07 104.63 7.89 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.4 mm -94.77 115.98 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -70.45 113.41 7.56 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.447 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.29 -29.31 67.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.952 0.796 . . . . 0.0 112.318 -175.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -23.99 67.01 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.287 1.435 . . . . 0.0 112.108 -176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.74 -5.78 5.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.955 1.302 . . . . 0.0 111.276 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 75' ' ' MET . 86.3 mt 41.27 49.46 3.32 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.114 2.165 . . . . 0.0 111.279 -162.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -123.66 158.43 31.57 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.413 0.685 . . . . 0.0 110.211 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.25 101.61 14.11 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 m -85.4 -27.76 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.396 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.27 -175.34 41.79 Favored Glycine 0 C--N 1.339 0.713 0 O-C-N 120.902 -1.124 . . . . 0.0 111.452 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -146.77 161.55 40.4 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.279 0.632 . . . . 0.0 110.764 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -93.13 124.73 37.31 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.808 1.643 . . . . 0.0 106.676 170.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.2 p -78.41 158.09 76.87 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.25 -8.42 23.4 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.057 1.838 . . . . 0.0 112.927 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.67 -8.29 39.25 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.844 166.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.27 47.05 8.53 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.889 1.344 . . . . 0.0 110.652 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -144.19 162.61 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -115.76 139.64 49.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.975 0.91 . . . . 0.0 109.469 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -124.43 142.29 51.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.433 1.493 . . . . 0.0 107.696 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.11 141.24 50.99 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.74 160.72 31.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.412 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 73.68 -169.81 53.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -156.35 157.93 36.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 106.9 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.3 t0 41.92 62.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.501 1.92 . . . . 0.0 112.207 172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.94 66.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -162.25 163.63 28.09 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 109.106 -160.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.5 m -138.13 165.96 25.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.749 2.02 . . . . 0.0 106.516 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -80.47 53.16 1.77 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.341 -1.474 . . . . 0.0 111.997 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -47.41 20.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.649 1.179 . . . . 0.0 110.535 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -71.33 77.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.276 1.43 . . . . 0.0 112.314 -173.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.9 -99.11 0.53 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.222 1.868 . . . . 0.0 111.962 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -74.76 -164.77 0.31 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.017 1.327 . . . . 0.0 109.601 172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.18 117.38 25.82 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.422 -1.424 . . . . 0.0 107.447 160.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 174.39 5.29 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.599 2.199 . . . . 0.0 112.089 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.66 143.51 50.96 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 161.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -84.42 132.01 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.536 1.134 . . . . 0.0 109.356 -165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.2 -12.82 60.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.906 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.32 -61.83 4.66 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.6 -170.55 1.96 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.06 2.144 . . . . 0.0 108.983 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.15 63.86 0.62 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 -141.84 12.35 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.521 1.534 . . . . 0.0 110.585 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 -173.38 2.36 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.202 1.001 . . . . 0.0 108.475 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -52.13 -31.69 32.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.834 1.254 . . . . 0.0 113.997 -167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -51.71 -48.21 63.65 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.17 -38.56 66.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.84 0.856 . . . . 0.0 111.195 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 159' ' ' VAL . 19.1 mt -64.73 -63.5 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.647 0.379 . . . . 0.0 110.901 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.88 1.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.781 1.232 . . . . 0.0 112.515 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.0 -100.76 2.52 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -81.79 -39.45 24.07 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -164.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.45 165.29 24.13 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -141.85 -170.16 12.35 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.674 1.607 . . . . 0.0 110.521 174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 124' ' ' LEU . 2.1 pt? -63.01 -3.6 1.75 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -59.41 -16.43 23.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.591 1.541 . . . . 0.0 112.704 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 36.2 p -84.75 -12.26 54.1 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.647 1.179 . . . . 0.0 113.608 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.09 126.75 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.392 1.451 . . . . 0.0 111.473 -163.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.37 153.59 42.31 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.462 1.505 . . . . 0.0 109.765 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.69 110.67 16.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 126.372 1.869 . . . . 0.0 106.768 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.3 168.5 36.57 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -62.09 -34.75 76.9 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.923 0.862 . . . . 0.0 112.21 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.15 82.88 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -69.41 -37.72 77.59 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 122.94 0.496 . . . . 0.0 111.192 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -46.26 84.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.0 m -57.81 -47.97 81.09 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.647 1.179 . . . . 0.0 110.012 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.7 ttp85 -58.72 -44.15 90.33 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 110.393 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.22 78.34 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.509 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.53 -49.5 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.706 1.139 . . . . 0.0 109.8 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -58.69 -48.38 81.3 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.976 0.91 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.25 -32.95 71.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.362 0.665 . . . . 0.0 112.045 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.28 -36.78 63.81 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.57 -45.29 77.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.917 0.781 . . . . 0.0 111.811 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.85 -8.22 27.32 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -88.44 87.74 7.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.027 1.285 . . . . 0.0 108.855 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -79.44 -13.44 59.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.452 -0.78 . . . . 0.0 112.246 165.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -135.4 164.44 27.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.214 2.206 . . . . 0.0 106.869 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.28 -8.18 16.71 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 30.1 tp -75.49 64.98 1.67 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.339 1.856 . . . . 0.0 111.265 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.06 84.6 3.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.913 157.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.44 -12.71 11.29 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.764 2.31 . . . . 0.0 113.284 171.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -63.84 -27.26 69.05 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -154.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.12 84.62 1.93 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 110.234 -170.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 57.3 28.36 15.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.928 1.691 . . . . 0.0 113.55 162.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.1 t -49.28 -42.77 42.03 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.515 1.526 . . . . 0.0 111.53 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 118' ' ' LEU . 28.2 mmtm -59.54 -46.83 87.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.197 1.399 . . . . 0.0 110.433 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.8 t -59.95 -49.77 76.36 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.733 0.813 . . . . 0.0 109.427 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -52.29 63.71 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.336 0.971 . . . . 0.0 111.444 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.85 -40.07 87.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.58 0.627 . . . . 0.0 111.894 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 118' ' ' LEU . 53.7 t -74.07 -24.91 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.818 1.19 . . . . 0.0 111.422 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -56.05 -47.62 77.55 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.461 -1.399 . . . . 0.0 109.196 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.24 -45.55 84.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 117.789 -1.1 . . . . 0.0 111.253 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 159' ' ' VAL . 1.2 p -61.67 -46.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.178 1.354 . . . . 0.0 110.266 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.71 -46.67 91.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.33 0.968 . . . . 0.0 109.832 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.7 ttm -62.27 -56.94 13.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.094 0.406 . . . . 0.0 110.924 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.3 t -84.98 -62.29 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 12.0 t -67.93 -55.81 11.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.832 0.853 . . . . 0.0 110.08 -166.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.85 -45.42 86.14 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.426 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -34.81 28.56 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.805 1.184 . . . . 0.0 114.325 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.3 tp -56.33 -40.53 74.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.846 1.323 . . . . 0.0 111.71 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.8 mtm105 -89.12 -52.45 5.07 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.082 0.953 . . . . 0.0 109.95 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -81.24 89.24 6.03 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.249 2.22 . . . . 0.0 110.329 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -41.25 -45.77 3.0 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.439 1.496 . . . . 0.0 110.627 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.0 t -48.57 -66.24 0.43 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.275 1.03 . . . . 0.0 111.57 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 -31.78 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 120.972 -1.08 . . . . 0.0 110.277 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -53.58 -48.04 69.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.912 0.778 . . . . 0.0 110.421 172.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -67.55 -41.99 83.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.502 1.046 . . . . 0.0 110.911 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.4 m -58.65 -44.89 90.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.75 0.705 . . . . 0.0 110.307 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.22 -52.42 60.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -52.93 -42.17 65.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.154 1.343 . . . . 0.0 112.696 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.8 -60.64 3.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.325 0.65 . . . . 0.0 110.74 172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -72.31 -34.25 61.02 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 122.014 -0.429 . . . . 0.0 113.872 -167.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -66.22 -11.78 52.06 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.968 1.307 . . . . 0.0 111.889 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -73.81 -20.25 60.52 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.243 -0.91 . . . . 0.0 112.317 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.3 p -94.72 173.05 7.8 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.396 0.998 . . . . 0.0 109.934 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -72.96 -59.91 2.48 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -75.51 -27.92 58.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.167 0.587 . . . . 0.0 112.477 -168.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.88 -165.38 36.34 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.85 0.75 . . . . 0.0 113.796 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.0 m -128.34 170.8 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.599 1.16 . . . . 0.0 110.29 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 17.8 m -123.6 141.03 52.4 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 190' ' ' LEU . 1.5 pt? -102.63 165.06 11.29 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.841 1.256 . . . . 0.0 111.539 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.8 t -89.67 163.43 15.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.516 0.727 . . . . 0.0 109.971 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.93 -27.46 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 124.748 1.219 . . . . 0.0 112.133 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.6 m -57.37 -51.98 67.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.234 1.013 . . . . 0.0 109.901 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -62.02 -44.25 97.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -53.22 -47.01 62.31 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.16 0.886 . . . . 0.0 113.342 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -68.71 -47.16 67.09 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.257 1.029 . . . . 0.0 109.758 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -53.52 -48.65 68.83 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.723 1.609 . . . . 0.0 111.775 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.09 -30.96 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 118.805 0.73 . . . . 0.0 112.352 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -69.4 -46.1 67.68 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.441 0.564 . . . . 0.0 110.582 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -99.96 53.2 0.91 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.178 0.591 . . . . 0.0 110.653 -164.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.4 t90 -56.57 -29.13 61.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.677 1.191 . . . . 0.0 112.051 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.86 -32.36 67.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.704 1.602 . . . . 0.0 113.06 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -66.26 -47.54 73.38 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.453 171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -64.27 -45.12 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 55.2 p -67.76 -42.47 81.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.361 0.982 . . . . 0.0 111.801 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -38.79 84.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.053 1.297 . . . . 0.0 110.981 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.18 85.01 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.91 0.777 . . . . 0.0 111.111 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.3 83.04 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.121 0.873 . . . . 0.0 110.935 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -65.92 -42.76 89.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.788 0.435 . . . . 0.0 110.962 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -35.06 79.53 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.056 -1.028 . . . . 0.0 111.519 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -72.28 -8.16 53.35 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.204 -0.935 . . . . 0.0 113.048 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.08 -48.25 12.43 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.356 1.434 . . . . 0.0 108.533 164.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.1 -41.33 96.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.569 1.148 . . . . 0.0 112.191 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -125.71 94.94 41.24 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.613 1.565 . . . . 0.0 108.711 173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -52.92 -28.09 37.97 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.348 3.365 . . . . 0.0 116.812 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.8 t -125.92 12.17 7.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.649 0.78 . . . . 0.0 112.099 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.48 165.09 17.41 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.674 173.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.52 95.53 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.17 116.58 50.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.466 1.107 . . . . 0.0 108.793 -170.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.01 -21.63 32.04 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.669 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -60.8 -22.39 64.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 111.874 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.6 tpp -119.43 -11.64 9.47 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.43 -35.37 77.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 110.877 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 224' ' ' LYS . 0.6 OUTLIER -63.05 -25.82 68.56 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.589 -0.694 . . . . 0.0 112.029 175.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.88 7.04 46.45 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.226 . . . . 0.0 110.795 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 85.4 5.15 85.35 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.834 1.207 . . . . 0.0 113.513 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.7 mt -101.16 110.22 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.238 1.519 . . . . 0.0 107.342 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 5.02 11.11 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -146.29 153.87 41.06 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -60.71 -38.0 83.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.177 0.591 . . . . 0.0 111.073 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.46 -36.35 83.91 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.684 0.675 . . . . 0.0 111.002 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.6 -47.04 87.28 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.65 78.83 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.635 -0.665 . . . . 0.0 110.496 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.72 -9.22 49.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -103.35 -16.36 15.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.218 1.372 . . . . 0.0 112.054 167.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.51 -47.45 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.42 1.009 . . . . 0.0 109.323 166.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.82 152.32 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.794 1.238 . . . . 0.0 110.041 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -101.28 -11.75 19.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.233 1.013 . . . . 0.0 112.275 171.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.8 mt -147.48 146.38 29.49 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.202 1.401 . . . . 0.0 107.502 -170.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.48 148.51 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.977 1.311 . . . . 0.0 108.586 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -68.38 158.71 32.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.13 127.82 33.71 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 163.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -130.65 100.52 5.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.6 m -58.93 -32.36 69.51 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.865 0.866 . . . . 0.0 111.698 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 p -138.15 135.87 36.12 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.29 1.836 . . . . 0.0 107.783 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -80.48 -19.8 45.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -152.4 98.7 2.42 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.736 1.214 . . . . 0.0 108.137 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 172.335 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.942 -0.075 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -77.17 62.09 2.19 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -162.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.71 165.82 18.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 109.817 155.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.82 97.5 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.32 129.34 91.87 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.95 155.36 11.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.651 2.901 . . . . 0.0 113.167 171.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -73.65 -30.42 62.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.55 0.34 . . . . 0.0 111.113 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.79 160.88 39.47 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.975 1.31 . . . . 0.0 109.095 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.8 m -137.54 94.46 2.92 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.9 pm0 -65.02 160.21 21.39 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.139 0.495 . . . . 0.0 110.345 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.04 138.66 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -126.36 102.2 27.05 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.602 0.761 . . . . 0.0 108.996 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -70.34 113.5 3.49 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.423 2.749 . . . . 0.0 110.094 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.71 -32.6 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.46 1.104 . . . . 0.0 110.305 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -35.85 65.78 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.62 0.768 . . . . 0.0 110.958 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.25 92.37 8.61 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.644 0.778 . . . . 0.0 110.301 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.97 79.71 0.65 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.206 1.002 . . . . 0.0 109.496 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -113.96 -65.01 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.079 1.351 . . . . 0.0 110.099 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -112.75 145.28 32.67 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.631 0.772 . . . . 0.0 109.758 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -84.56 172.12 9.37 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 111.587 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -58.81 -35.25 72.55 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.883 0.873 . . . . 0.0 111.872 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 t -47.41 -51.36 20.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.056 0.942 . . . . 0.0 110.959 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.44 95.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.975 0.51 . . . . 0.0 111.323 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.04 -53.68 52.11 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.222 0.609 . . . . 0.0 110.09 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 -44.79 97.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.979 0.912 . . . . 0.0 108.989 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.64 85.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.325 0.966 . . . . 0.0 111.104 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -58.54 -55.81 30.29 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.521 0.729 . . . . 0.0 110.119 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.7 t -60.97 -42.67 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.895 -0.503 . . . . 0.0 110.061 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -57.84 -56.02 27.35 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.577 1.151 . . . . 0.0 110.378 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -59.42 -37.02 76.99 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.487 0.585 . . . . 0.0 110.634 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.51 -51.4 57.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.287 0.494 . . . . 0.0 111.489 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.12 -18.97 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -169.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -52.67 -31.89 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.395 0.998 . . . . 0.0 111.347 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -56.8 -31.44 64.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.086 0.857 . . . . 0.0 112.44 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -103.05 -5.75 23.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.455 1.102 . . . . 0.0 112.196 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.8 m -80.07 176.76 9.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.176 0.99 . . . . 0.0 110.654 171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 m -116.68 127.85 54.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.549 2.34 . . . . 0.0 106.664 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.06 146.29 37.39 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 167.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -136.9 148.2 46.9 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 108.866 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.5 145.11 52.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.9 0.09 17.55 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 117.72 -1.6 . . . . 0.0 115.563 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.1 mt -113.93 117.19 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 120.359 2.079 . . . . 0.0 105.686 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.41 -44.56 90.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.788 176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -66.85 139.76 95.87 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 109.475 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.37 156.85 63.2 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.121 1.881 . . . . 0.0 110.358 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.82 131.31 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.39 159.39 85.67 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.322 -0.861 . . . . 0.0 110.876 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.18 160.67 44.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.87 2.38 . . . . 0.0 111.907 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.23 146.04 32.87 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.1 2.533 . . . . 0.0 112.613 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -76.92 119.63 20.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -131.74 162.82 29.58 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.479 1.111 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -88.05 2.68 51.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.414 0.686 . . . . 0.0 112.595 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.09 73.44 80.78 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 109.738 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -59.46 133.5 52.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.255 1.97 . . . . 0.0 110.062 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.88 -42.77 69.59 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -144.87 167.96 21.37 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.996 1.718 . . . . 0.0 109.308 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.416 ' CZ3' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -160.61 173.64 15.2 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.38 1.472 . . . . 0.0 109.664 175.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.87 145.76 29.64 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.078 0.951 . . . . 0.0 109.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -150.81 93.65 1.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.077 0.551 . . . . 0.0 109.662 -172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -89.61 124.47 34.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.252 0.621 . . . . 0.0 110.069 -172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.66 100.11 3.28 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -82.23 128.31 34.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -131.43 141.04 49.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.907 0.776 . . . . 0.0 110.707 -169.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.2 p -127.27 176.68 7.23 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.64 1.576 . . . . 0.0 108.931 158.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -60.79 -22.53 64.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.494 1.118 . . . . 0.0 112.291 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.99 -43.86 4.54 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 111.329 -168.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 m -145.44 166.15 26.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.154 0.982 . . . . 0.0 111.381 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.7 m -143.09 162.55 35.23 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.1 pt -142.78 153.06 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 161.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 94.33 4.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.85 135.62 36.13 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.233 0.613 . . . . 0.0 110.409 -172.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' CZ3' ' A' ' 57' ' ' TRP . . . -103.83 118.09 35.87 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.253 1.021 . . . . 0.0 109.102 -174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.49 108.87 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -72.9 116.2 13.12 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -53.99 -32.82 55.27 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.925 0.784 . . . . 0.0 111.993 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.8 -36.71 74.9 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.913 1.685 . . . . 0.0 111.097 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.24 -12.04 12.52 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.76 -0.588 . . . . 0.0 111.878 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.83 51.68 1.83 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.089 1.756 . . . . 0.0 109.148 -161.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -134.77 158.13 44.96 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.943 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tt -84.72 86.86 7.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.26 -28.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 122.005 -0.434 . . . . 0.0 111.531 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.23 175.14 47.51 Favored Glycine 0 C--N 1.337 0.598 0 O-C-N 121.649 -0.657 . . . . 0.0 111.727 170.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -146.37 158.98 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.311 0.645 . . . . 0.0 110.392 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -104.77 148.24 26.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.87 0.868 . . . . 0.0 109.162 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -98.11 146.27 31.23 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.07 138.23 78.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.173 2.582 . . . . 0.0 111.014 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.24 43.13 64.03 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.27 -179.39 34.06 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.873 1.701 . . . . 0.0 110.005 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -96.45 178.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.854 0.862 . . . . 0.0 110.02 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -81.1 150.57 28.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.822 0.849 . . . . 0.0 109.584 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -123.11 116.98 24.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 127.341 2.257 . . . . 0.0 107.34 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -98.85 135.13 40.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.771 1.628 . . . . 0.0 109.956 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -66.83 98.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 162.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.73 -173.79 43.34 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -145.84 169.21 19.01 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.181 1.392 . . . . 0.0 110.17 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t0 23.72 82.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.282 3.033 . . . . 0.0 114.615 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.32 78.84 0.59 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.68 143.37 50.87 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.644 0.778 . . . . 0.0 110.849 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.7 p -93.03 173.02 7.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.691 1.196 . . . . 0.0 110.446 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.94 -0.81 36.7 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.515 -0.74 . . . . 0.0 112.352 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.75 159.47 19.25 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 69.52 -2.26 1.97 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.921 1.688 . . . . 0.0 111.744 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.32 -91.08 1.54 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -74.8 169.8 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -63.05 112.51 6.96 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 110.712 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.77 168.63 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.762 2.308 . . . . 0.0 110.3 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 145.43 24.55 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 159.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 11.6 p-90 -87.41 155.51 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.407 0.549 . . . . 0.0 110.344 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.18 -22.83 26.77 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.655 0.782 . . . . 0.0 112.871 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.42 -37.83 3.36 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.365 0.983 . . . . 0.0 112.742 171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -146.29 128.38 15.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -167.83 71.51 0.16 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.09 2.29 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.69 -174.36 4.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.599 1.56 . . . . 0.0 108.716 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -48.92 -31.7 7.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 113.815 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -56.85 -32.7 66.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.978 0.911 . . . . 0.0 111.748 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -74.99 -32.65 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.843 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.3 mt -68.07 -64.9 0.77 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 123.674 0.79 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.85 -0.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.08 0.952 . . . . 0.0 113.11 -168.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.93 -100.97 1.9 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.06 -38.82 17.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -161.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -52.03 67.22 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -164.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.52 155.29 11.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.263 0.935 . . . . 0.0 110.896 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.96 -3.76 34.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.559 1.144 . . . . 0.0 113.74 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -16.73 54.77 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.684 1.194 . . . . 0.0 114.112 -175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -63.77 -23.97 67.57 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.809 0.844 . . . . 0.0 111.673 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.68 134.95 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 122.922 0.489 . . . . 0.0 109.897 -168.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 m -77.48 151.41 34.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.757 0.823 . . . . 0.0 109.931 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.6 mtm -128.79 142.18 51.07 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 126.89 2.076 . . . . 0.0 107.012 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.53 172.71 33.26 Favored Glycine 0 N--CA 1.467 0.707 0 CA-C-N 119.925 1.239 . . . . 0.0 110.188 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -52.66 -61.41 2.3 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.56 1.18 . . . . 0.0 113.186 -171.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.77 85.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.965 0.506 . . . . 0.0 110.397 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.9 -31.53 72.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.436 1.094 . . . . 0.0 110.442 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -50.89 51.8 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 124.426 1.09 . . . . 0.0 109.792 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 29.1 m -55.34 -48.25 74.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 110.364 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -51.16 -54.75 22.49 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.14 0.976 . . . . 0.0 109.623 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.24 -55.54 33.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.213 0.605 . . . . 0.0 112.305 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -64.89 -38.62 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 118.758 0.708 . . . . 0.0 110.624 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -59.25 -54.19 49.75 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.76 -21.21 60.26 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.874 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.5 tp -74.94 -31.89 61.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.022 1.283 . . . . 0.0 111.676 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.44 57.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.546 0.738 . . . . 0.0 112.749 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -68.69 -9.85 52.83 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm -67.59 88.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.238 0.926 . . . . 0.0 109.754 -174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -75.84 -23.83 55.77 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.613 -0.679 . . . . 0.0 110.053 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -142.25 157.65 44.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.029 2.532 . . . . 0.0 106.637 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.87 113.2 4.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 166.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.8 tp -135.2 139.14 44.3 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.071 1.348 . . . . 0.0 107.745 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 33.12 62.24 1.53 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.464 2.305 . . . . 0.0 114.387 -171.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.75 -4.32 6.99 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.969 3.113 . . . . 0.0 115.622 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -106.66 -3.83 20.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.022 1.329 . . . . 0.0 112.07 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.69 -112.51 0.33 Allowed 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.164 0.893 . . . . 0.0 110.352 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -59.35 -41.5 89.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.522 1.129 . . . . 0.0 111.363 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.1 p -49.78 -46.0 50.29 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.807 1.643 . . . . 0.0 111.163 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -63.35 -49.32 74.35 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.831 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.5 t -56.47 -43.34 79.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -63.28 -56.88 12.83 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.198 0.999 . . . . 0.0 110.37 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.34 -55.33 36.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.522 1.529 . . . . 0.0 111.456 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.68 -27.5 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.372 -171.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -56.59 -51.23 69.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.605 1.093 . . . . 0.0 109.572 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 9.1 mp -63.43 -43.87 96.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.935 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -42.48 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 119.614 1.097 . . . . 0.0 110.277 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.27 -38.68 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.384 0.993 . . . . 0.0 109.467 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.1 ttm -69.13 -66.53 0.57 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.884 -0.51 . . . . 0.0 110.756 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.16 -54.77 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -168.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 19.6 t -69.99 -56.48 6.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -167.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -61.86 -34.73 76.52 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.43 -25.25 57.61 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.086 0.851 . . . . 0.0 113.859 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.51 -25.36 60.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.952 1.376 . . . . 0.0 111.521 175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . 0.252 36.0 ptt180 -112.77 -19.44 12.0 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.206 0.912 . . . . 0.0 113.106 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 81.2 m-85 -119.75 111.48 18.06 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.676 1.99 . . . . 0.0 108.06 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -62.54 -32.44 73.39 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.195 0.598 . . . . 0.0 110.151 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.6 m -59.48 -52.88 63.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.845 0.858 . . . . 0.0 110.896 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.71 -36.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 121.084 -1.01 . . . . 0.0 110.816 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -50.25 74.19 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.222 0.919 . . . . 0.0 109.238 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -34.55 71.52 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.102 1.319 . . . . 0.0 112.487 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.0 m -62.78 -52.89 61.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.67 -27.98 35.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.58 1.082 . . . . 0.0 112.138 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.9 -49.71 75.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.663 1.574 . . . . 0.0 109.084 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.53 -2.49 17.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.787 1.235 . . . . 0.0 113.521 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.61 -32.97 3.46 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.786 1.66 . . . . 0.0 112.157 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -74.62 -32.36 62.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.944 1.698 . . . . 0.0 110.544 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -84.95 -3.42 58.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.852 0.861 . . . . 0.0 112.77 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.5 t -83.12 159.74 22.02 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 165.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -79.99 -34.31 38.64 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.403 0.681 . . . . 0.0 111.565 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -101.07 -36.37 9.01 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.557 0.617 . . . . 0.0 112.169 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 108.85 -171.1 15.17 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.566 -0.613 . . . . 0.0 111.566 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.0 168.13 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 108.856 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 5.6 p -116.67 148.98 40.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.032 1.733 . . . . 0.0 108.104 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.6 pt? -84.32 -176.45 6.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.194 0.598 . . . . 0.0 109.627 167.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -124.82 169.11 12.35 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 109.887 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.29 -45.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 126.0 1.72 . . . . 0.0 110.127 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.5 m -54.95 -45.82 74.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 110.501 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.49 -49.76 67.82 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.37 0.668 . . . . 0.0 109.458 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.35 -52.74 31.13 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -61.15 -48.59 80.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.739 -0.648 . . . . 0.0 110.917 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.9 -40.69 95.48 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.236 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.1 m -66.93 -33.44 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.912 1.233 . . . . 0.0 111.254 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -8.74 57.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -127.96 51.43 1.96 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.799 1.181 . . . . 0.0 111.191 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -58.57 -30.32 67.08 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.273 -0.892 . . . . 0.0 112.339 170.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -46.49 68.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.193 1.397 . . . . 0.0 111.122 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -67.37 -41.09 85.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.488 1.115 . . . . 0.0 110.679 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.465 HG21 HG11 ' A' ' 237' ' ' VAL . 1.6 mp -56.94 -46.99 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 65.3 m -63.46 -42.69 98.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.039 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -61.04 -43.82 98.32 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.971 1.259 . . . . 0.0 110.646 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.88 -41.82 98.34 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 118.581 0.628 . . . . 0.0 110.63 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.851 0.86 . . . . 0.0 110.997 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -65.19 -42.43 93.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.984 0.356 . . . . 0.0 110.982 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -45.9 92.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.049 0.94 . . . . 0.0 110.395 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -69.2 -12.76 61.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.608 1.163 . . . . 0.0 113.731 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.57 -50.64 20.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.868 1.213 . . . . 0.0 108.982 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.85 -39.99 66.06 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.073 0.549 . . . . 0.0 111.642 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -136.85 97.2 11.28 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.481 1.112 . . . . 0.0 109.698 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -22.7 32.0 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.375 2.05 . . . . 0.0 113.092 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 t -67.61 -24.53 65.49 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.522 0.729 . . . . 0.0 112.0 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -72.07 108.81 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.858 0.863 . . . . 0.0 110.411 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 t -76.92 104.26 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.6 mt -68.48 118.64 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.694 1.198 . . . . 0.0 108.693 -172.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.05 -47.52 12.41 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.07 2.514 . . . . 0.0 112.122 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -24.52 67.03 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.899 0.88 . . . . 0.0 113.224 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 39.4 tpp -93.87 -24.27 17.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.523 1.129 . . . . 0.0 112.122 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -60.22 -34.27 73.42 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.139 -0.976 . . . . 0.0 111.416 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -71.88 -17.16 62.13 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.81 -0.556 . . . . 0.0 112.009 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.03 -2.28 58.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.417 1.087 . . . . 0.0 110.956 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.84 -23.83 18.43 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.603 . . . . 0.0 112.987 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.81 110.89 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -168.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -17.74 21.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.78 162.99 36.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.984 1.266 . . . . 0.0 111.881 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -73.9 -26.73 60.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -170.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -72.03 -40.38 68.45 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.43 -45.58 88.18 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.283 0.633 . . . . 0.0 110.006 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.62 75.61 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.356 0.526 . . . . 0.0 110.575 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.41 76.52 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.125 0.97 . . . . 0.0 113.309 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -78.5 -30.58 47.26 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.102 1.319 . . . . 0.0 111.517 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 28.0 mt -74.77 -41.16 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.428 1.013 . . . . 0.0 110.521 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 204' ' ' ILE . 5.1 m -114.3 143.95 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.428 1.467 . . . . 0.0 111.97 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -85.98 -42.16 14.24 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.566 1.146 . . . . 0.0 111.484 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.6 mp -139.4 164.43 29.89 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.789 1.235 . . . . 0.0 107.765 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.9 159.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.943 0.897 . . . . 0.0 109.522 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.27 157.84 24.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.862 0.865 . . . . 0.0 108.926 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -60.19 135.97 57.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -135.71 98.21 3.86 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.2 m -57.59 149.43 21.5 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.842 0.857 . . . . 0.0 109.192 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.3 m -65.84 92.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.754 1.222 . . . . 0.0 109.124 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.88 104.2 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.245 1.018 . . . . 0.0 108.958 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.36 91.88 2.25 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 172.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.074 1.75 . . . . 0.0 108.073 179.096 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.27 35.15 0.07 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.669 1.988 . . . . 0.0 114.199 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.85 80.34 1.8 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.111 1.765 . . . . 0.0 107.183 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.11 123.66 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -90.99 135.03 29.1 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.94 144.8 84.04 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 121.941 1.76 . . . . 0.0 110.019 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -64.02 -39.15 93.46 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.2 -0.313 . . . . 0.0 110.833 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.68 148.96 43.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.489 1.516 . . . . 0.0 108.135 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -91.79 119.93 32.05 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 167.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -91.76 120.17 32.25 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.84 130.81 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.84 113.67 59.31 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.135 1.374 . . . . 0.0 108.536 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.07 132.34 48.78 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 110.704 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.4 t -102.46 -28.78 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 122.743 0.417 . . . . 0.0 109.979 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -13.65 41.06 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.514 -0.741 . . . . 0.0 112.814 -168.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.52 127.22 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 43.33 0.32 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.309 1.444 . . . . 0.0 112.08 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.02 -32.05 66.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.417 1.087 . . . . 0.0 112.005 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -128.49 111.42 19.31 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 125.59 1.556 . . . . 0.0 109.237 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.44 158.79 18.01 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.621 2.214 . . . . 0.0 110.984 164.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -64.64 -42.1 95.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.731 174.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -54.22 -47.8 71.74 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.726 0.693 . . . . 0.0 109.427 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -53.72 51.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.772 0.829 . . . . 0.0 111.221 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.93 -52.4 65.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.672 0.389 . . . . 0.0 111.21 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.95 -44.43 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.702 1.201 . . . . 0.0 109.746 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -46.25 86.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.599 1.091 . . . . 0.0 110.657 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t -55.91 -50.07 71.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.542 0.737 . . . . 0.0 110.494 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.7 t -62.63 -37.81 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.604 -0.685 . . . . 0.0 110.256 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -61.39 -46.05 91.81 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.06 -1.025 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.73 -36.98 70.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.955 0.798 . . . . 0.0 110.408 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.2 -51.53 44.56 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 119.213 -0.422 . . . . 0.0 111.207 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p -66.16 -23.57 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.455 1.025 . . . . 0.0 112.081 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.8 -21.72 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 O-C-N 120.838 -1.164 . . . . 0.0 111.246 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -64.92 -30.0 70.97 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.302 -1.499 . . . . 0.0 111.098 172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -104.53 -23.54 13.12 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 112.278 -169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.8 p -57.53 153.88 12.19 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.538 0.685 . . . . 0.0 111.928 -171.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 p -94.55 165.91 12.3 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.129 0.972 . . . . 0.0 109.159 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.4 140.51 44.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.754 1.222 . . . . 0.0 108.469 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -137.64 136.72 37.73 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 162.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -65.06 158.32 26.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.17 -45.93 2.89 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.425 1.012 . . . . 0.0 112.652 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.4 mt -66.15 120.37 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 118.763 1.282 . . . . 0.0 107.817 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.9 -47.11 66.62 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.354 0.662 . . . . 0.0 110.496 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -70.29 160.15 82.06 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.376 1.07 . . . . 0.0 111.099 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.34 149.54 84.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.152 1.901 . . . . 0.0 109.885 168.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 t -101.23 140.08 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.96 146.36 99.01 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.124 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 151.0 34.56 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.282 1.988 . . . . 0.0 112.599 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.16 162.31 40.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 109.916 165.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.9 137.16 45.44 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 122.08 -0.388 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -124.25 155.83 37.91 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.583 1.553 . . . . 0.0 109.223 172.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -65.98 -62.21 1.62 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.425 1.09 . . . . 0.0 110.444 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.06 86.29 17.85 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.416 1.487 . . . . 0.0 108.203 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -70.13 167.61 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.305 2.003 . . . . 0.0 110.872 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -68.93 -27.27 65.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.875 -0.516 . . . . 0.0 112.131 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.77 168.42 25.12 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.065 1.346 . . . . 0.0 109.554 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -159.2 176.07 12.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.621 1.968 . . . . 0.0 107.771 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.95 97.43 8.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -111.34 109.81 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.419 1.888 . . . . 0.0 107.21 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -129.31 110.37 11.88 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.81 134.56 33.92 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.02 102.06 11.51 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -80.98 136.38 36.0 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -120.01 175.28 5.99 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 155.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.7 ptt-85 -73.06 -11.98 60.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.375 -0.828 . . . . 0.0 112.331 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.62 -24.17 5.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.175 1.39 . . . . 0.0 112.384 -171.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -151.82 179.85 8.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.57 1.148 . . . . 0.0 110.351 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 p -150.85 158.19 43.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.4 pt -141.85 163.61 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 164.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -106.58 129.92 54.43 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -84.95 120.23 26.27 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 162.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.56 104.79 16.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.5 mm -106.58 118.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -79.33 111.47 15.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -58.63 -25.24 62.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.632 0.651 . . . . 0.0 111.696 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.73 -19.96 66.07 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.449 1.5 . . . . 0.0 112.436 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -130.39 -33.57 1.67 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.21 1.004 . . . . 0.0 112.867 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt 46.72 65.44 1.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.876 1.67 . . . . 0.0 112.591 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -130.24 -102.46 0.3 Allowed 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 152.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -161.36 146.5 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.22 -26.71 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 118.343 0.52 . . . . 0.0 111.914 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.6 -175.98 44.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -134.74 157.73 45.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -104.62 132.7 50.56 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.8 p -99.71 158.1 32.73 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.22 117.05 3.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.268 2.646 . . . . 0.0 109.199 164.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -49.84 0.57 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.59 -29.23 2.79 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.938 167.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.3 m -89.57 170.44 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.719 1.259 . . . . 0.0 111.188 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -111.26 153.77 25.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.543 1.137 . . . . 0.0 109.933 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -109.19 121.87 46.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.727 1.611 . . . . 0.0 107.412 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -92.25 134.59 34.75 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.75 1.22 . . . . 0.0 108.949 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -81.62 100.02 9.19 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.73 -179.04 48.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.58 142.88 32.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.445 1.098 . . . . 0.0 108.958 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.8 t0 31.21 74.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.655 2.782 . . . . 0.0 113.948 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.58 82.94 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.68 147.85 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.778 0.431 . . . . 0.0 109.848 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.5 p -142.18 167.77 21.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.277 1.031 . . . . 0.0 111.01 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -73.25 11.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.667 1.187 . . . . 0.0 113.522 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.04 -33.88 72.63 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.102 -1.624 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.65 11.39 5.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.475 1.11 . . . . 0.0 112.663 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.35 -86.53 1.55 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -73.81 167.2 21.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 167.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -72.0 113.48 20.66 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.978 1.711 . . . . 0.0 109.058 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -84.29 -165.81 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.907 1 C-N-CA 125.446 4.097 . . . . 0.0 111.103 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -116.11 131.28 56.99 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 166.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -79.06 147.77 32.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.304 0.502 . . . . 0.0 110.143 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.18 -29.81 38.73 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.43 1.37 59.18 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.94 0.781 . . . . 0.0 112.579 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -156.95 177.16 11.82 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.601 1.56 . . . . 0.0 109.67 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.01 175.11 13.75 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.207 1.384 . . . . 0.0 112.828 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.81 -118.87 5.29 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.955 1.265 . . . . 0.0 112.289 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.44 144.68 7.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.123 1.769 . . . . 0.0 113.598 -169.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -56.63 -30.12 62.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.857 1.263 . . . . 0.0 113.444 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -57.73 -37.08 72.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.204 1.002 . . . . 0.0 110.733 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.02 -32.05 50.84 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.961 0.905 . . . . 0.0 111.985 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 HG11 ' A' ' 159' ' ' VAL . 88.2 mt -63.3 -68.62 0.33 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.266 0.626 . . . . 0.0 110.02 -173.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.96 -3.18 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.295 1.038 . . . . 0.0 112.359 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.3 -78.52 1.83 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.441 1.019 . . . . 0.0 111.501 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -61.5 -44.79 96.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.096 0.958 . . . . 0.0 112.452 -171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -101.81 156.06 17.75 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.896 0.878 . . . . 0.0 109.578 -175.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.7 -173.61 45.61 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 pt? -64.22 -4.91 4.1 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.056 0.943 . . . . 0.0 113.253 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -49.68 -24.58 2.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.657 1.983 . . . . 0.0 114.106 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.554 1.142 . . . . 0.0 112.698 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 124' ' ' LEU . 23.0 m -77.88 99.2 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.771 1.168 . . . . 0.0 111.295 -171.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -60.92 143.31 55.27 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 13.0 mmt -105.4 133.15 50.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.537 1.535 . . . . 0.0 106.931 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 169.49 163.85 24.21 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.98 0.809 . . . . 0.0 111.169 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -62.68 -41.2 98.96 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.898 -0.766 . . . . 0.0 112.603 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.37 89.65 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.026 0.53 . . . . 0.0 110.392 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -63.56 -45.4 90.67 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.482 0.713 . . . . 0.0 109.357 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.8 mtp -61.11 -49.58 76.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.841 -0.599 . . . . 0.0 111.422 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.5 m -58.34 -43.67 88.41 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.789 0.722 . . . . 0.0 110.599 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -63.03 -49.79 73.24 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 122.999 0.519 . . . . 0.0 110.364 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.76 84.54 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.002 0.819 . . . . 0.0 112.622 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.77 -45.54 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.762 0.71 . . . . 0.0 109.349 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -60.57 -41.9 95.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.585 0.63 . . . . 0.0 110.749 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -69.14 -39.57 78.75 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.212 1.005 . . . . 0.0 110.976 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 mt -79.17 -34.36 43.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.604 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.61 70.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.431 1.014 . . . . 0.0 112.71 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -79.63 -3.66 48.18 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -75.9 75.22 2.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.561 1.528 . . . . 0.0 110.969 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.8 -88.27 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 153.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -73.17 -21.56 60.67 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.68 89.33 1.76 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 pp -121.3 9.61 10.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.361 1.464 . . . . 0.0 111.974 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -62.98 116.83 27.26 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.432 1.493 . . . . 0.0 110.128 -173.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.63 -20.48 58.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.829 175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -66.53 -26.99 67.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.041 0.937 . . . . 0.0 111.533 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.32 143.96 51.85 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.12 9.02 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.511 1.524 . . . . 0.0 113.553 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 49.9 p -53.25 -27.05 20.34 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.989 1.316 . . . . 0.0 111.902 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -47.55 -48.61 27.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.787 1.635 . . . . 0.0 111.016 170.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 47.9 t -61.82 -51.66 67.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -48.68 74.87 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.456 -0.778 . . . . 0.0 111.334 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.26 -43.76 93.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 118.156 -0.926 . . . . 0.0 112.043 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 118' ' ' LEU . 25.3 m -69.39 -37.47 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.076 1.307 . . . . 0.0 110.84 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -55.27 -46.33 76.13 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.277 1.031 . . . . 0.0 110.027 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.17 -56.2 21.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.484 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.37 -37.05 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.824 1.193 . . . . 0.0 110.91 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.57 -43.23 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.406 0.683 . . . . 0.0 109.628 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.8 ttm -71.19 -24.94 62.32 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.972 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.8 -79.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.197 0.908 . . . . 0.0 110.62 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -72.38 -26.68 61.99 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.919 -1.113 . . . . 0.0 112.278 -166.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -48.93 78.0 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 169.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -50.59 -40.85 40.9 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.221 0.915 . . . . 0.0 112.849 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.5 tp -53.8 -34.83 60.36 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.389 1.094 . . . . 0.0 112.833 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -112.23 -8.32 13.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 118.131 -0.938 . . . . 0.0 113.329 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 56.0 m-85 -119.98 96.55 5.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.099 1.76 . . . . 0.0 109.412 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -47.6 -42.45 24.0 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.849 1.26 . . . . 0.0 110.729 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.2 t -53.41 -67.29 0.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.405 0.682 . . . . 0.0 110.815 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.59 -33.39 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.085 -1.01 . . . . 0.0 109.867 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 7.0 t -52.99 -55.38 24.01 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.824 0.738 . . . . 0.0 109.576 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -69.95 -33.96 72.8 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.702 -0.624 . . . . 0.0 111.579 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.9 m -59.39 -51.2 70.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.15 0.886 . . . . 0.0 109.928 172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.0 t -64.83 -37.45 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 121.638 -0.664 . . . . 0.0 109.565 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.83 -49.56 75.05 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.456 1.102 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.58 -31.84 72.18 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.283 0.633 . . . . 0.0 111.944 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.28 -22.2 48.97 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.41 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -58.7 -41.96 87.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.655 1.727 . . . . 0.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -68.84 -21.12 64.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.492 -0.766 . . . . 0.0 112.367 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.9 t -67.08 132.73 48.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.352 0.978 . . . . 0.0 109.535 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.79 -30.06 70.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 167.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -79.52 -30.17 41.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.2 0.6 . . . . 0.0 110.788 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.39 -174.28 50.33 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.14 160.77 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.392 1.077 . . . . 0.0 108.903 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.5 p -132.57 106.83 8.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.754 1.221 . . . . 0.0 108.621 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.6 144.1 55.73 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.943 -0.473 . . . . 0.0 109.972 172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.4 t -84.21 174.69 9.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.288 0.635 . . . . 0.0 110.441 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.15 -50.99 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.769 1.628 . . . . 0.0 109.644 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 m -56.87 -46.0 82.11 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.008 1.323 . . . . 0.0 110.702 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -61.27 -52.52 64.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.976 0.91 . . . . 0.0 109.104 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -50.19 -53.27 24.18 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.551 1.072 . . . . 0.0 111.932 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -64.56 -43.16 94.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.069 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.53 -40.2 96.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.858 1.208 . . . . 0.0 111.386 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 21.8 m -71.22 -32.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.606 1.093 . . . . 0.0 111.38 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -69.42 -31.61 70.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.967 0.507 . . . . 0.0 111.44 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.63 57.81 0.65 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.508 1.049 . . . . 0.0 111.167 -175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -56.69 -27.38 58.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.652 1.581 . . . . 0.0 112.683 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -55.6 -38.8 69.89 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -69.73 -36.32 75.77 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.725 -0.609 . . . . 0.0 110.667 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 3.0 mp -66.96 -43.74 89.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.3 m -57.79 -49.6 76.05 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.52 0.6 . . . . 0.0 111.689 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -37.09 84.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.577 1.08 . . . . 0.0 111.843 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.57 98.59 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.137 0.88 . . . . 0.0 110.602 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.49 -45.91 90.32 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.368 0.667 . . . . 0.0 110.971 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -61.15 -46.23 91.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.818 0.342 . . . . 0.0 110.546 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -61.77 -44.86 96.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.637 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -64.55 -34.32 77.96 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.13 -35.64 79.37 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.595 0.634 . . . . 0.0 110.703 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.7 -35.95 24.1 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -125.68 103.66 27.98 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.84 1.256 . . . . 0.0 110.255 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.67 -12.11 26.51 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.18 2.586 . . . . 0.0 114.695 -168.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.6 t -125.6 12.35 8.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.515 1.126 . . . . 0.0 111.316 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.94 122.17 16.35 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 121.109 -0.994 . . . . 0.0 109.278 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.89 102.16 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 165.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.71 111.19 23.99 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.77 -32.94 55.56 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.274 1.982 . . . . 0.0 111.467 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.31 -40.77 65.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.888 1.675 . . . . 0.0 109.851 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 26.5 tpp -94.23 -32.4 13.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.311 1.044 . . . . 0.0 111.143 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -58.02 -29.45 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.854 -0.529 . . . . 0.0 111.296 169.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -62.3 -39.86 94.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.547 0.612 . . . . 0.0 111.306 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.05 -23.03 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.905 0.482 . . . . 0.0 111.096 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 112.89 -6.0 25.74 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.616 1.579 . . . . 0.0 113.532 172.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.0 mt -82.9 121.55 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -97.67 -15.33 20.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.86 155.48 37.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.48 1.036 . . . . 0.0 111.126 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -55.15 -40.35 70.52 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.953 0.901 . . . . 0.0 113.288 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.05 -36.46 72.34 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.57 1.077 . . . . 0.0 109.791 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.49 -42.71 99.21 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.693 0.797 . . . . 0.0 109.144 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.12 71.18 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.271 -0.893 . . . . 0.0 110.909 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.79 78.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.057 0.943 . . . . 0.0 112.344 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -76.77 -22.26 54.0 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.85 0.75 . . . . 0.0 112.336 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.91 -50.14 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.316 1.047 . . . . 0.0 110.018 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.57 179.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.048 0.84 . . . . 0.0 110.994 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -132.03 -16.94 2.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.336 1.455 . . . . 0.0 112.743 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -146.32 169.55 18.59 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.937 . . . . 0.0 107.116 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.0 159.5 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.847 1.259 . . . . 0.0 109.109 166.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -63.05 171.66 2.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.751 1.22 . . . . 0.0 110.507 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -67.44 73.07 0.14 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.703 2.001 . . . . 0.0 112.181 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -77.57 52.34 0.97 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.518 1.527 . . . . 0.0 110.551 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.5 t -74.35 -37.49 63.49 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.9 m -64.53 128.62 36.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.184 1.394 . . . . 0.0 109.321 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -65.97 -35.87 81.76 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.681 0.393 . . . . 0.0 111.384 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.28 102.85 3.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.401 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 169.014 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -75.96 62.66 1.64 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.038 1.335 . . . . 0.0 112.75 -176.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -113.73 169.11 9.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.134 1.773 . . . . 0.0 108.348 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 129.51 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.91 125.65 79.49 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.429 -0.796 . . . . 0.0 108.87 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.98 127.72 27.53 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.919 2.413 . . . . 0.0 111.386 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -72.77 -54.59 8.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -152.52 170.51 19.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.213 1.405 . . . . 0.0 108.76 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 t -144.02 127.0 16.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.15 114.85 21.62 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.62 126.01 60.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.21 138.89 30.16 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.602 0.761 . . . . 0.0 110.07 173.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -62.47 139.31 75.75 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.866 1.711 . . . . 0.0 108.62 161.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.24 -6.94 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.48 -12.92 60.04 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -142.8 122.23 13.16 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.81 98.39 0.54 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.477 1.111 . . . . 0.0 110.688 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -121.66 -12.01 8.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.178 . . . . 0.0 112.209 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -146.95 149.4 35.63 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.138 1.775 . . . . 0.0 107.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.69 153.84 34.23 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.031 1.821 . . . . 0.0 109.763 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -62.36 -29.14 70.26 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.663 -0.648 . . . . 0.0 111.064 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t -49.75 -45.62 49.6 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.212 1.005 . . . . 0.0 110.99 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.43 65.05 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.323 0.649 . . . . 0.0 110.996 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.84 -52.38 65.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.631 0.772 . . . . 0.0 110.364 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.11 -48.21 87.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.289 1.036 . . . . 0.0 109.495 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.81 92.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.91 0.777 . . . . 0.0 111.2 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.6 t -56.48 -57.42 12.38 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.364 0.666 . . . . 0.0 109.861 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.25 -41.6 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.989 -0.444 . . . . 0.0 110.335 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -53.62 -57.58 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.412 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.91 -39.96 83.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.538 0.608 . . . . 0.0 110.74 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.99 -54.31 36.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.413 0.551 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.33 -26.73 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.006 0.821 . . . . 0.0 111.362 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.66 -28.4 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 121.123 -0.985 . . . . 0.0 111.394 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -72.12 -8.02 52.3 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.728 -1.232 . . . . 0.0 112.625 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -128.88 -6.03 5.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.647 1.112 . . . . 0.0 113.157 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.9 p -81.09 177.08 9.27 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.147 -0.97 . . . . 0.0 111.646 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 m -82.37 152.42 26.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.752 1.221 . . . . 0.0 109.453 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -64.21 170.37 3.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.394 1.078 . . . . 0.0 111.58 168.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -123.49 136.24 54.48 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.449 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -67.32 -56.49 9.56 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.386 0.674 . . . . 0.0 110.312 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.63 31.35 0.47 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.852 1.215 . . . . 0.0 111.155 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.0 mt -95.59 142.37 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -66.25 -44.2 84.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 109.962 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -78.84 154.38 78.07 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.294 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.16 163.1 30.22 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.494 2.796 . . . . 0.0 111.396 162.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.94 134.1 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 124.848 1.259 . . . . 0.0 107.738 -175.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.02 159.21 66.46 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 121.878 -0.514 . . . . 0.0 111.59 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.61 163.72 26.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.934 2.423 . . . . 0.0 111.418 171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.93 169.65 14.43 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.813 2.342 . . . . 0.0 111.651 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -68.79 91.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.366 1.467 . . . . 0.0 109.963 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -90.23 135.39 33.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.013 1.325 . . . . 0.0 108.526 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -64.76 -44.28 90.58 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.22 0.464 . . . . 0.0 112.098 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.51 114.04 15.64 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.289 1.035 . . . . 0.0 109.305 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.66 164.43 28.16 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.402 2.068 . . . . 0.0 111.307 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -79.38 -42.77 24.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.081 0.552 . . . . 0.0 109.996 168.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.61 163.75 34.84 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.217 1.407 . . . . 0.0 109.483 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -159.49 173.55 16.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.14 93.64 8.81 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -168.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -77.81 120.71 23.09 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 164.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -126.71 127.65 45.46 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -123.47 110.28 14.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.874 0.87 . . . . 0.0 109.116 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.03 111.29 23.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -98.36 156.23 16.84 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.668 1.587 . . . . 0.0 109.74 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.4 p -131.76 178.39 6.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.201 1.8 . . . . 0.0 107.612 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -55.7 -48.02 75.82 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 120.958 -1.089 . . . . 0.0 109.351 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -78.84 -44.5 22.84 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.751 0.821 . . . . 0.0 111.624 -171.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.2 m -148.98 -178.24 6.25 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.563 0.745 . . . . 0.0 111.737 -157.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 t -155.76 163.37 39.94 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.175 -0.953 . . . . 0.0 109.201 167.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 pt -142.29 134.7 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.989 1.315 . . . . 0.0 108.747 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.69 90.16 5.59 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -71.94 121.2 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.39 117.47 30.92 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.8 mm -116.07 113.73 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -84.87 122.26 28.91 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.963 -1.085 . . . . 0.0 109.908 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -55.5 -27.94 51.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.046 0.939 . . . . 0.0 112.933 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.24 -31.0 71.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.061 0.945 . . . . 0.0 111.595 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -123.95 -13.28 7.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.61 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.8 mt 27.24 70.37 0.05 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 128.28 2.632 . . . . 0.0 111.39 -158.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -133.45 157.93 44.35 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.839 0.856 . . . . 0.0 108.983 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.2 88.46 7.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -70.63 -29.96 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.892 -0.505 . . . . 0.0 111.902 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.67 175.98 44.45 Favored Glycine 0 C--N 1.337 0.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.959 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -132.58 141.39 48.68 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.184 0.594 . . . . 0.0 110.57 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.3 ttp180 -78.26 146.62 34.75 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 p -104.43 133.16 20.35 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 157.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.82 -25.13 45.94 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.889 1.726 . . . . 0.0 113.705 -162.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.04 19.3 53.91 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.57 1.081 . . . . 0.0 112.348 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 -147.81 4.92 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.92 1.248 . . . . 0.0 110.844 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.42 -169.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.218 1.407 . . . . 0.0 109.751 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -85.41 151.54 23.92 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.312 1.045 . . . . 0.0 110.616 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -124.0 114.57 19.93 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.809 2.044 . . . . 0.0 106.266 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.75 134.48 38.63 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.435 1.094 . . . . 0.0 109.454 -168.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -79.74 99.59 7.51 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.23 -172.07 41.44 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.155 1.359 . . . . 0.0 109.997 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -150.79 169.15 22.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.706 2.002 . . . . 0.0 107.341 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.89 84.02 0.1 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.907 2.083 . . . . 0.0 112.191 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.31 90.44 1.88 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.44 143.95 32.9 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.023 0.529 . . . . 0.0 109.813 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -100.86 145.17 28.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.543 0.687 . . . . 0.0 110.702 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.52 -12.02 59.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.604 0.761 . . . . 0.0 111.888 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.96 -38.14 67.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.442 1.097 . . . . 0.0 111.355 -173.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.06 -1.65 6.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.132 0.973 . . . . 0.0 113.253 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.58 -85.67 0.61 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.19 176.79 9.44 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 169.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.31 107.4 1.92 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.659 1.584 . . . . 0.0 108.652 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 178.84 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.031 1.821 . . . . 0.0 110.044 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -119.43 117.6 28.9 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -67.55 143.82 55.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.015 0.825 . . . . 0.0 109.959 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 mt -74.74 -23.06 58.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.543 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.36 7.0 65.75 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 0.0 112.91 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -144.87 167.54 22.37 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.571 1.548 . . . . 0.0 109.724 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -121.27 159.17 15.9 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -91.36 79.17 1.33 Allowed Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.785 -0.832 . . . . 0.0 111.191 -173.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 153.25 42.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.101 0.961 . . . . 0.0 108.515 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -60.89 -32.23 71.69 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.961 1.255 . . . . 0.0 111.452 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -57.11 -32.97 66.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.789 1.236 . . . . 0.0 111.574 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -68.87 -36.28 77.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.949 0.9 . . . . 0.0 110.824 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -80.13 -61.12 2.08 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.174 0.99 . . . . 0.0 109.02 -167.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.75 -4.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.035 0.934 . . . . 0.0 113.259 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.87 -72.3 2.86 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.317 0.962 . . . . 0.0 112.008 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -104.54 13.94 30.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.844 1.258 . . . . 0.0 114.37 -160.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 140.32 52.13 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.35 175.76 52.61 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.67 6.99 32.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 113.593 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.63 -32.65 69.24 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.26 -0.9 . . . . 0.0 111.125 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -69.14 -13.75 62.6 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.46 1.104 . . . . 0.0 113.425 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.87 120.85 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 m -64.26 148.9 49.15 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.73 0.812 . . . . 0.0 110.037 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -110.47 134.77 52.04 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.315 1.446 . . . . 0.0 107.348 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.89 171.61 40.67 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -45.79 92.92 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.242 1.021 . . . . 0.0 112.64 -170.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.74 82.86 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.019 0.528 . . . . 0.0 110.282 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -67.54 -39.0 85.03 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 122.015 -0.428 . . . . 0.0 110.164 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -53.52 57.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 11.8 m -53.47 -55.48 24.94 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.887 1.275 . . . . 0.0 111.436 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -56.93 -45.13 82.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.632 0.773 . . . . 0.0 109.859 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.11 -47.66 81.87 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.856 -0.592 . . . . 0.0 112.172 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.48 -48.14 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.304 0.956 . . . . 0.0 109.979 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -59.36 -46.28 89.07 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 123.492 0.717 . . . . 0.0 109.964 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.42 -52.19 66.68 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.677 0.791 . . . . 0.0 111.524 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.05 -35.31 76.58 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.05 0.54 . . . . 0.0 111.393 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.87 -53.86 23.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.756 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -74.31 -23.35 59.06 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -165.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.83 136.3 58.03 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.161 0.891 . . . . 0.0 108.611 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 128.33 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 1 C-N-CA 132.468 4.307 . . . . 0.0 107.336 -163.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -71.26 -68.72 0.42 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 162.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -71.25 152.62 43.12 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 59.1 tp -146.36 80.23 1.56 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.59 73.03 9.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.455 0.702 . . . . 0.0 110.914 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.92 -8.52 22.83 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.439 2.759 . . . . 0.0 114.882 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.45 -19.52 62.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.315 1.446 . . . . 0.0 113.102 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.36 -171.28 1.73 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.895 1.278 . . . . 0.0 111.975 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.9 2.98 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.211 1.805 . . . . 0.0 113.477 170.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -51.03 -31.48 18.5 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.678 1.991 . . . . 0.0 111.73 168.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 118' ' ' LEU . 14.2 mmmm -62.22 -44.39 96.67 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.372 1.069 . . . . 0.0 110.341 171.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.6 m -65.21 -39.73 93.19 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.786 -1.196 . . . . 0.0 111.281 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -53.6 -50.81 64.83 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 0.0 111.363 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.3 pp -66.84 -35.72 80.7 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.015 0.825 . . . . 0.0 112.333 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.485 HG21 HD21 ' A' ' 118' ' ' LEU . 71.6 t -65.98 -42.53 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.419 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . 0.26 18.2 ptpt -61.12 -42.03 97.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.203 1.365 . . . . 0.0 110.81 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.25 -52.34 65.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.358 0.981 . . . . 0.0 111.808 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.0 p -61.9 -45.0 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.772 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.22 -35.75 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 119.969 1.259 . . . . 0.0 111.299 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 79.3 mtp -63.87 -67.08 0.46 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.495 0.718 . . . . 0.0 110.126 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.31 -51.37 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -167.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.85 -57.45 8.81 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -70.12 -17.77 63.22 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 121.54 -0.725 . . . . 0.0 111.485 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -53.54 -25.69 28.73 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.014 1.293 . . . . 0.0 113.689 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.12 -33.82 72.32 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.454 1.627 . . . . 0.0 111.862 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -56.04 3.44 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.31 0.959 . . . . 0.0 109.727 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.79 87.19 7.07 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.388 1.075 . . . . 0.0 108.96 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -53.41 -30.85 42.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.746 0.248 . . . . 0.0 111.431 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.01 -38.24 87.88 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.698 -0.626 . . . . 0.0 111.921 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -41.87 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 120.495 -1.378 . . . . 0.0 108.94 -177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -49.37 77.95 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.939 0.791 . . . . 0.0 111.002 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -35.74 73.5 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.689 1.131 . . . . 0.0 111.436 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 40.1 m -68.89 -53.9 18.59 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.11 -32.21 55.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-N 119.354 0.979 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -58.09 -38.84 77.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.265 1.393 . . . . 0.0 111.815 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.59 93.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.958 0.503 . . . . 0.0 110.88 174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.78 87.98 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 123.209 0.433 . . . . 0.0 112.248 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.38 -47.7 84.92 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 126.626 1.971 . . . . 0.0 109.837 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -78.2 17.03 0.67 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.794 1.238 . . . . 0.0 112.431 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -132.49 155.56 48.34 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.052 1.341 . . . . 0.0 109.742 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -81.86 -25.12 35.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.083 0.553 . . . . 0.0 111.255 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.16 -25.57 39.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.072 0.549 . . . . 0.0 111.268 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.0 -175.02 32.33 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.93 171.06 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.868 0.867 . . . . 0.0 109.33 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -132.26 91.39 2.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.84 1.656 . . . . 0.0 106.914 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.51 136.57 58.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 t -68.83 158.24 34.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.54 0.336 . . . . 0.0 110.733 -168.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.25 -35.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.336 1.054 . . . . 0.0 110.332 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.9 m -62.17 -36.38 81.7 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -72.24 -47.12 52.8 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.528 -0.732 . . . . 0.0 109.22 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -51.25 -46.73 51.42 Favored Glycine 0 N--CA 1.465 0.621 0 C-N-CA 124.646 1.117 . . . . 0.0 112.425 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -63.08 -52.65 61.88 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.727 0.811 . . . . 0.0 110.745 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -60.17 -35.27 74.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.025 0.829 . . . . 0.0 112.152 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.02 -11.56 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.284 0.947 . . . . 0.0 112.887 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.63 -40.05 73.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.849 1.204 . . . . 0.0 111.085 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -121.21 67.91 0.88 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.263 0.625 . . . . 0.0 109.941 -161.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -59.62 -24.27 63.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.436 0.694 . . . . 0.0 111.759 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.084 0.954 . . . . 0.0 112.973 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -67.38 -42.91 82.61 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.296 -0.877 . . . . 0.0 108.913 173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 237' ' ' VAL . 1.8 mp -61.0 -49.34 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.849 0.86 . . . . 0.0 109.569 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.8 p -61.04 -50.59 72.69 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.232 0.924 . . . . 0.0 109.853 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -60.43 -36.37 78.01 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.673 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.06 -54.78 36.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.852 1.206 . . . . 0.0 110.631 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.28 -39.1 89.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.701 0.4 . . . . 0.0 111.147 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -62.29 -48.04 81.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.357 1.463 . . . . 0.0 110.498 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -65.75 -37.09 85.42 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.958 -1.089 . . . . 0.0 110.759 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -67.79 -8.51 36.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -83.25 -38.49 22.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.524 1.511 . . . . 0.0 110.326 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.83 -42.67 90.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.503 0.721 . . . . 0.0 111.147 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -133.28 103.07 12.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.833 1.253 . . . . 0.0 109.388 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.97 -40.96 66.28 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.933 3.089 . . . . 0.0 114.425 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.2 t -96.87 13.53 28.42 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.044 0.938 . . . . 0.0 111.57 -173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.61 159.75 8.08 Favored 'General case' 0 C--N 1.345 0.371 0 O-C-N 121.089 -1.007 . . . . 0.0 110.402 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.87 140.88 46.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.6 mt -129.78 90.1 44.27 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -166.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -51.74 -37.02 64.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.64 2.893 . . . . 0.0 113.599 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -59.76 -34.64 73.23 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.599 0.76 . . . . 0.0 110.738 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.33 -34.44 21.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.527 1.131 . . . . 0.0 110.621 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.9 -33.27 68.57 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.64 -0.663 . . . . 0.0 111.052 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 224' ' ' LYS . 0.1 OUTLIER -59.4 -33.06 70.75 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.901 0.773 . . . . 0.0 111.744 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 2.11 38.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.325 1.05 . . . . 0.0 111.854 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.2 7.15 70.35 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.788 1.185 . . . . 0.0 113.02 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.4 mt -107.85 105.02 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -3.13 18.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -148.65 155.26 40.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.06 0.846 . . . . 0.0 108.906 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -59.1 -35.83 74.1 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.948 -0.47 . . . . 0.0 110.718 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -59.39 -35.55 74.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.547 0.739 . . . . 0.0 111.746 175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -69.81 -51.29 34.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.739 -0.601 . . . . 0.0 111.866 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.81 73.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.708 1.603 . . . . 0.0 112.008 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -85.24 -28.75 25.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.659 0.663 . . . . 0.0 112.159 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.79 -51.41 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.209 0.913 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 204' ' ' ILE . 2.4 m -121.38 139.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.33 0.968 . . . . 0.0 110.981 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -93.55 -20.16 20.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.07 158.69 42.94 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.126 1.33 . . . . 0.0 108.601 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.13 143.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.11 0.564 . . . . 0.0 109.795 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -60.09 157.98 12.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -62.98 144.66 56.65 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -143.43 93.08 2.44 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 t -67.02 126.73 30.07 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 24.8 m -141.57 159.0 43.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.58 1.552 . . . . 0.0 107.703 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.46 81.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.038 0.935 . . . . 0.0 112.028 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.2 43.61 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.159 1.384 . . . . 0.0 107.674 176.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -11.34 60.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -108.72 153.8 22.94 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.285 . . . . 0.0 109.704 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.01 133.63 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.54 121.16 69.45 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.71 167.08 22.07 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.625 2.217 . . . . 0.0 111.456 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 55' ' ' GLU . 1.1 mptp? -122.33 -176.32 3.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.183 1.393 . . . . 0.0 108.881 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.36 102.83 0.12 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.853 1.261 . . . . 0.0 109.605 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 t -67.96 169.74 9.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.487 0.715 . . . . 0.0 109.325 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -122.97 127.83 49.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -105.91 129.29 59.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.272 1.429 . . . . 0.0 107.704 -170.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -125.38 109.9 26.4 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.808 1.643 . . . . 0.0 108.519 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.94 98.17 0.19 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.225 2.617 . . . . 0.0 110.361 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.52 -17.42 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 121.481 -0.762 . . . . 0.0 110.805 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -64.29 -45.97 85.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.202 0.601 . . . . 0.0 111.173 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.21 94.28 8.25 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.195 -167.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 103.27 0.38 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.843 0.857 . . . . 0.0 109.017 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -140.81 -67.51 0.42 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.602 1.161 . . . . 0.0 109.502 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -72.3 142.85 85.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 138.01 76.01 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 0.0 110.354 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -63.57 -32.04 73.39 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.444 -0.785 . . . . 0.0 110.652 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.8 t -56.88 -44.16 82.0 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 170.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.21 89.76 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -54.22 -53.27 55.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.166 0.586 . . . . 0.0 110.177 172.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -57.74 -44.97 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.073 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -53.26 59.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.602 1.092 . . . . 0.0 110.964 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -59.1 -50.79 72.7 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.888 0.767 . . . . 0.0 111.657 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.76 -37.85 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.639 -0.663 . . . . 0.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -61.81 -48.56 80.06 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.209 -0.932 . . . . 0.0 110.231 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -45.51 71.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.437 0.695 . . . . 0.0 109.211 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.93 -56.34 15.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.913 0.485 . . . . 0.0 111.632 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.44 -27.77 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.761 0.71 . . . . 0.0 112.108 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.03 -30.92 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.196 0.907 . . . . 0.0 110.717 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -63.98 -18.33 64.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.883 1.22 . . . . 0.0 112.295 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -104.44 2.45 31.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.208 1.403 . . . . 0.0 112.319 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.76 177.88 4.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.387 0.994 . . . . 0.0 110.725 176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -120.43 138.99 53.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.13 94.73 9.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.776 0.83 . . . . 0.0 108.925 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -74.1 147.62 42.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 165.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -63.3 156.94 24.17 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 122.008 -0.432 . . . . 0.0 110.339 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.82 -56.22 3.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.684 1.135 . . . . 0.0 113.304 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 mt -63.13 114.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.304 1.442 . . . . 0.0 107.531 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.66 -56.51 11.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.971 0.509 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -68.89 152.41 96.79 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.952 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -49.11 145.93 13.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.592 3.528 . . . . 0.0 114.361 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.91 146.06 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.578 1.151 . . . . 0.0 108.131 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.2 mt -64.84 156.37 79.63 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.852 -0.53 . . . . 0.0 111.426 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.14 162.89 8.69 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.034 2.489 . . . . 0.0 112.751 163.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 150.56 18.67 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 112.039 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.2 134.31 52.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -145.15 150.52 36.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -74.58 -4.46 37.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.08 81.63 57.09 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.658 1.183 . . . . 0.0 109.736 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -71.46 100.84 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.549 2.166 . . . . 0.0 108.479 169.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' O ' ' HE2' ' A' ' 7' ' ' LYS . 17.0 tp10 -62.17 -49.44 75.81 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.239 0.616 . . . . 0.0 109.798 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.36 158.9 40.75 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.846 1.258 . . . . 0.0 110.334 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.8 171.9 18.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.256 1.822 . . . . 0.0 108.711 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.71 100.43 12.0 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -84.43 133.66 34.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 164.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 m -136.69 104.87 5.66 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 117.53 23.92 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.351 1.06 . . . . 0.0 108.817 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.12 113.87 27.7 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -102.55 138.8 38.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.718 0.807 . . . . 0.0 109.526 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.97 177.21 7.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.44 1.496 . . . . 0.0 108.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -53.05 -37.79 61.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.805 1.184 . . . . 0.0 113.458 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 p -116.35 -65.16 1.22 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.32 1.448 . . . . 0.0 108.997 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -89.69 160.87 16.38 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.046 0.938 . . . . 0.0 112.164 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.7 p -148.36 140.8 24.33 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.8 pt -132.4 126.87 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 119.289 0.95 . . . . 0.0 109.458 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -74.12 107.94 6.62 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 155.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -94.71 152.93 18.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.13 124.15 24.23 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.487 0.315 . . . . 0.0 110.33 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.6 112.86 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ttp85 -77.06 111.27 12.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -31.59 69.06 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.292 -172.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -14.6 62.09 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.652 1.115 . . . . 0.0 113.679 -173.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -133.73 0.49 3.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.073 0.949 . . . . 0.0 112.463 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 66.9 mt 40.32 68.62 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.545 2.338 . . . . 0.0 111.451 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -139.57 153.85 47.5 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.915 -0.491 . . . . 0.0 109.787 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.42 97.41 4.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 87.7 t -78.04 -27.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.634 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.24 -178.96 48.05 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.082 0.856 . . . . 0.0 112.779 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -142.61 159.79 41.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.624 0.769 . . . . 0.0 111.199 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -93.3 109.53 21.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.992 2.117 . . . . 0.0 108.459 174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.1 m -66.6 135.03 94.42 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 164.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.3 132.05 32.37 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.023 1.816 . . . . 0.0 108.689 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.06 -6.17 23.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.283 0.944 . . . . 0.0 112.989 -172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.64 54.55 2.34 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 118.669 1.234 . . . . 0.0 111.8 170.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.69 153.72 25.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 160.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -124.07 149.14 46.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.96 135.01 54.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -120.99 142.64 49.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.892 1.677 . . . . 0.0 107.264 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -68.56 160.14 30.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.818 0.847 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.97 -169.19 52.87 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.37 166.5 30.82 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.917 0.887 . . . . 0.0 112.237 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.81 -63.18 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 129.974 3.31 . . . . 0.0 114.304 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.47 84.0 1.3 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.289 -1.925 . . . . 0.0 108.289 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.73 160.74 7.03 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.318 0.647 . . . . 0.0 110.763 169.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -133.7 28.1 3.95 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.478 1.511 . . . . 0.0 109.61 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -26.25 92.54 0.01 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 128.446 2.698 . . . . 0.0 114.733 -158.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.67 -17.01 13.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.528 0.731 . . . . 0.0 111.452 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.17 33.64 0.15 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.345 1.458 . . . . 0.0 111.514 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.88 -89.65 0.77 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.048 1.309 . . . . 0.0 110.223 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -75.3 175.25 8.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.334 0.653 . . . . 0.0 110.584 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -65.51 109.29 2.89 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.215 . . . . 0.0 110.13 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.8 171.15 18.72 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.555 2.17 . . . . 0.0 111.687 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.86 161.95 13.74 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.8 1.24 . . . . 0.0 108.749 163.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -95.44 130.0 42.41 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.461 0.704 . . . . 0.0 111.228 -170.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.3 mt -68.46 -19.05 64.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.64 -32.33 7.14 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.171 0.896 . . . . 0.0 112.544 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -141.86 -174.6 4.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.854 1.262 . . . . 0.0 109.797 -166.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.41 164.74 21.55 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.555 1.074 . . . . 0.0 110.653 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.59 78.12 1.63 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.17 33.4 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.6 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -57.85 -31.78 66.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.712 1.142 . . . . 0.0 112.931 -166.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.25 -44.39 33.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.056 1.742 . . . . 0.0 111.194 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.42 -52.98 9.46 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 122.162 -0.336 . . . . 0.0 110.414 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 159' ' ' VAL . 82.0 mt -46.81 -59.42 3.08 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.06 1.344 . . . . 0.0 111.816 -161.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 pt -141.23 33.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.322 1.849 . . . . 0.0 108.676 -168.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.32 -126.74 36.44 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.79 -10.28 59.76 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.4 140.49 57.17 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -87.81 167.18 36.37 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.94 -10.24 59.26 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 5.72 15.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.89 0.876 . . . . 0.0 112.464 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.6 p -61.97 -19.46 62.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.41 1.084 . . . . 0.0 112.468 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.7 147.56 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.799 1.24 . . . . 0.0 110.339 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 m -68.79 160.81 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.984 1.314 . . . . 0.0 109.168 172.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.3 mmt -119.34 130.32 55.3 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.923 2.089 . . . . 0.0 107.248 176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.8 44.1 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -71.06 -25.79 62.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.703 1.252 . . . . 0.0 111.647 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.55 92.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.6 1.091 . . . . 0.0 110.493 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -59.92 -39.43 85.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.073 0.949 . . . . 0.0 109.654 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.2 ttt -64.68 -47.19 79.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 117.824 -1.084 . . . . 0.0 110.92 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.1 m -53.14 -50.44 64.54 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.702 1.201 . . . . 0.0 110.21 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -58.76 -47.99 82.74 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.81 -0.557 . . . . 0.0 110.181 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.92 88.5 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -42.58 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.23 1.377 . . . . 0.0 110.531 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -62.64 -42.24 99.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.377 0.608 . . . . 0.0 110.083 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.73 -49.15 78.67 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.068 1.347 . . . . 0.0 111.679 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.69 -37.46 86.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.057 0.389 . . . . 0.0 109.99 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.29 82.84 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.61 -8.87 57.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.951 1.25 . . . . 0.0 113.044 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.68 80.16 2.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.95 1.704 . . . . 0.0 108.867 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -79.14 -24.85 43.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.427 0.691 . . . . 0.0 110.503 164.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -136.19 -174.32 3.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.336 2.254 . . . . 0.0 108.242 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.08 -30.31 25.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 117.529 -1.224 . . . . 0.0 113.712 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.5 tt 13.81 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 131.224 3.81 . . . . 0.0 114.304 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.61 71.69 1.04 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.925 2.09 . . . . 0.0 112.148 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.65 -37.82 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.313 2.008 . . . . 0.0 112.891 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -92.37 -14.36 28.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.63 1.172 . . . . 0.0 112.519 -166.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.78 -167.8 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.33 1.062 . . . . 0.0 111.408 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.18 -6.27 2.95 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 124.973 1.309 . . . . 0.0 112.278 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.8 p -46.83 -41.85 16.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.132 2.173 . . . . 0.0 111.326 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -54.03 -49.49 68.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.093 1.357 . . . . 0.0 111.142 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.9 t -64.61 -41.12 96.41 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.828 1.251 . . . . 0.0 111.05 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -64.58 -47.22 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.806 -1.184 . . . . 0.0 110.658 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.58 -40.59 92.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.133 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 118' ' ' LEU 0.273 33.3 m -69.16 -41.03 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 118.451 -1.3 . . . . 0.0 112.124 -178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -32.06 71.76 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.126 1.33 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.58 -54.39 32.88 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.816 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.2 p -61.68 -35.9 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 120.333 1.424 . . . . 0.0 110.57 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 167' ' ' GLU . 83.2 t -61.84 -48.11 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.109 0.868 . . . . 0.0 109.406 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 80.1 mtm -74.81 11.15 1.13 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.239 1.015 . . . . 0.0 113.291 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.98 -78.3 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 119.805 1.184 . . . . 0.0 108.905 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.61 -54.44 39.59 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 119.272 0.942 . . . . 0.0 109.944 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -67.19 -39.05 86.32 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.092 -176.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.81 93.35 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.397 1.453 . . . . 0.0 112.351 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 31.5 tp -69.21 -40.7 77.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.904 0.882 . . . . 0.0 110.684 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -72.45 -46.16 56.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.816 -0.612 . . . . 0.0 111.474 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.438 ' CD2' HG22 ' A' ' 237' ' ' VAL . 81.7 m-85 -116.21 102.14 9.32 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.376 2.67 . . . . 0.0 109.127 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -57.73 -28.91 64.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.221 1.008 . . . . 0.0 112.076 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -58.32 -60.13 4.25 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.504 0.593 . . . . 0.0 109.792 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.27 -34.73 67.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 O-C-N 121.625 -0.672 . . . . 0.0 109.89 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -52.4 63.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.548 0.613 . . . . 0.0 110.64 176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -64.48 -32.32 73.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.145 0.884 . . . . 0.0 112.27 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 50.9 m -60.69 -59.84 4.75 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.358 0.981 . . . . 0.0 109.447 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.91 -20.16 23.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.135 -171.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.42 -42.35 77.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.005 1.73 . . . . 0.0 111.393 170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.27 79.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.154 0.582 . . . . 0.0 110.938 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.27 -44.2 29.24 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -56.38 -49.22 75.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.794 2.038 . . . . 0.0 110.506 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -79.25 -9.53 59.6 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.2 t -89.73 156.97 18.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.32 1.048 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.92 -23.74 28.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.552 0.741 . . . . 0.0 111.664 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -91.43 -31.64 15.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.513 0.725 . . . . 0.0 111.641 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.11 -178.16 53.6 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.44 171.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.475 1.51 . . . . 0.0 108.824 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.8 m -125.77 115.3 19.82 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 160.05 10.79 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 110.15 172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 14.3 t -107.41 161.43 14.82 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.858 0.463 . . . . 0.0 110.273 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.93 -39.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.984 1.314 . . . . 0.0 111.229 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 m -57.31 -49.94 74.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.462 1.105 . . . . 0.0 109.586 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -62.95 -50.87 69.11 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.312 0.645 . . . . 0.0 109.576 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.08 -52.33 36.2 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 123.703 0.668 . . . . 0.0 112.012 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -64.97 -48.47 73.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.351 0.66 . . . . 0.0 109.926 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -52.97 -52.38 58.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.553 1.141 . . . . 0.0 110.922 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.95 -36.46 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 118.631 0.65 . . . . 0.0 111.783 -172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -73.32 -27.69 61.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.581 0.628 . . . . 0.0 111.225 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -98.3 40.59 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.888 1.275 . . . . 0.0 110.712 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -54.16 -27.55 34.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.749 1.22 . . . . 0.0 112.63 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.73 -38.77 22.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.253 1.421 . . . . 0.0 112.781 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -64.72 -38.82 92.3 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.389 -0.819 . . . . 0.0 110.641 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.68 -47.37 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.9 m -53.27 -49.26 67.28 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.443 1.019 . . . . 0.0 111.689 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -64.06 -48.5 76.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.164 1.347 . . . . 0.0 111.023 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.4 -33.03 71.9 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.584 0.629 . . . . 0.0 112.02 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.71 93.65 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.716 0.806 . . . . 0.0 111.012 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -69.76 -43.14 72.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.226 0.466 . . . . 0.0 110.196 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.04 -44.87 83.38 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.909 0.884 . . . . 0.0 110.232 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -79.32 -14.42 59.01 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.81 -41.18 75.36 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.661 -1.274 . . . . 0.0 108.735 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -75.3 -54.05 7.73 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.02 0.528 . . . . 0.0 111.538 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.84 112.21 63.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.837 1.255 . . . . 0.0 109.194 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -51.87 -45.17 40.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.25 2.633 . . . . 0.0 114.694 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 8.5 t -151.78 79.96 1.27 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 164.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.7 45.39 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.558 -0.714 . . . . 0.0 109.235 166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.85 127.41 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 163.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.7 mt -126.54 91.06 48.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 -32.09 76.24 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.989 1.793 . . . . 0.0 111.327 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.13 -8.63 8.26 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.493 1.917 . . . . 0.0 112.795 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 40.5 tpp -117.48 -37.68 3.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.396 1.478 . . . . 0.0 110.417 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -56.21 -31.41 63.45 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.394 0.678 . . . . 0.0 111.534 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -59.32 -29.1 67.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.679 0.672 . . . . 0.0 112.365 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.18 10.02 31.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.849 1.26 . . . . 0.0 111.446 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 86.94 -6.81 82.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.29 1.424 . . . . 0.0 113.714 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.4 mt -89.18 100.47 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.27 -8.86 31.69 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.94 160.53 43.05 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 109.302 -173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -57.75 -39.99 78.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.824 0.449 . . . . 0.0 110.891 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -61.59 -37.54 84.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.228 0.467 . . . . 0.0 110.514 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -66.24 -47.95 72.1 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.89 82.67 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.719 -0.613 . . . . 0.0 111.106 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -66.39 -29.45 69.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.046 1.339 . . . . 0.0 113.061 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -84.49 -39.27 19.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.3 0.955 . . . . 0.0 110.798 172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 48.4 mt -69.94 -37.81 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.68 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 171' ' ' PHE . 6.8 t -127.51 147.7 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.269 1.395 . . . . 0.0 108.906 -175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -131.86 8.73 4.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.218 1.007 . . . . 0.0 113.559 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.0 mt -148.17 129.68 14.91 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.32 158.43 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 110.699 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.02 161.67 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.427 1.091 . . . . 0.0 110.068 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.96 90.49 0.44 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.782 0.833 . . . . 0.0 110.352 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -78.48 68.36 4.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.3 t -71.21 -39.18 71.89 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 170.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 m -65.85 136.08 55.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.777 1.231 . . . . 0.0 109.469 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -67.74 166.96 14.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.21 0.604 . . . . 0.0 110.789 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -77.49 85.32 3.87 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.173 0.989 . . . . 0.0 109.421 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 167.037 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.27 4.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -135.25 160.09 39.49 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.411 1.884 . . . . 0.0 108.649 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.11 154.41 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.46 114.6 38.14 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 158.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.83 150.57 78.72 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.037 1.825 . . . . 0.0 110.306 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -81.12 -30.15 34.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.74 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -151.15 171.36 17.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.192 1.397 . . . . 0.0 108.077 167.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -140.58 131.68 26.34 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -96.77 105.67 17.83 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.187 1.395 . . . . 0.0 108.607 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.9 mt -105.77 122.17 58.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.14 105.0 20.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 125.37 1.468 . . . . 0.0 109.287 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.34 109.36 1.77 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.191 2.594 . . . . 0.0 109.599 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.44 -42.54 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.588 1.155 . . . . 0.0 109.981 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -81.71 -6.22 58.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.82 100.37 11.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.29 74.11 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -121.41 -25.23 5.23 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.107 1.763 . . . . 0.0 111.91 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.51 145.32 34.12 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.452 1.501 . . . . 0.0 108.665 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.76 165.26 17.92 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.376 2.717 . . . . 0.0 109.9 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.61 -42.89 71.68 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.347 -0.845 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.4 t -51.12 -43.18 61.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.061 1.344 . . . . 0.0 111.059 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -49.64 68.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.303 0.502 . . . . 0.0 111.404 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -39.3 75.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.592 0.633 . . . . 0.0 110.276 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -58.95 -41.69 83.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.602 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.38 77.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.152 0.887 . . . . 0.0 110.219 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t -53.31 -45.8 69.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.008 0.523 . . . . 0.0 110.533 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.61 -46.04 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.819 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -62.26 -35.79 80.06 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.636 1.562 . . . . 0.0 111.339 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -57.37 -37.54 72.79 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.948 0.795 . . . . 0.0 110.488 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.33 -44.33 79.38 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.843 0.747 . . . . 0.0 111.854 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.91 -33.22 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.917 1.235 . . . . 0.0 110.554 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.24 -26.86 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.575 175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -56.97 -40.33 76.31 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.554 -1.341 . . . . 0.0 111.082 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -124.18 28.24 6.81 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 111.651 -171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.3 p -70.64 179.35 2.62 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.454 -0.779 . . . . 0.0 110.44 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.9 m -114.08 142.09 46.65 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 166.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.2 127.67 37.76 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -114.65 128.95 56.6 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -60.93 147.2 44.05 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.04 -12.48 11.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.777 1.18 . . . . 0.0 114.402 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -102.42 124.03 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -70.59 -55.37 8.98 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.3 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -68.73 147.17 97.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.963 1.305 . . . . 0.0 110.329 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.76 160.48 14.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.717 2.278 . . . . 0.0 113.381 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.87 146.02 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.0 mt -68.06 156.2 90.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.319 -0.863 . . . . 0.0 111.382 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.07 166.36 21.12 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.109 2.54 . . . . 0.0 111.34 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.65 159.3 37.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.995 2.463 . . . . 0.0 112.577 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.59 82.58 8.35 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.934 1.294 . . . . 0.0 108.183 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -72.4 165.24 24.94 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.527 0.731 . . . . 0.0 110.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.95 -51.1 69.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.774 0.429 . . . . 0.0 110.529 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.6 112.13 29.38 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.512 1.125 . . . . 0.0 109.198 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.09 115.67 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.333 2.022 . . . . 0.0 110.012 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -83.49 -16.92 43.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.203 0.601 . . . . 0.0 111.819 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.5 114.41 7.32 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.531 1.132 . . . . 0.0 109.142 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -151.4 172.61 15.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.928 1.691 . . . . 0.0 108.192 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.9 mt -111.32 151.19 28.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.561 0.696 . . . . 0.0 111.76 -160.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.9 121.98 29.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.672 1.989 . . . . 0.0 105.728 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -125.75 117.66 23.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -106.68 103.88 13.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.842 0.857 . . . . 0.0 109.033 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp -74.93 121.12 21.43 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -111.32 142.42 43.57 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.925 1.29 . . . . 0.0 108.432 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 p -130.84 -176.67 4.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.368 1.467 . . . . 0.0 108.474 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -52.62 -52.26 56.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.933 0.893 . . . . 0.0 110.669 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -92.48 -38.83 11.74 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.326 -165.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.5 m -148.1 -173.78 4.4 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.171 0.896 . . . . 0.0 111.746 -168.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.5 p -156.06 166.83 32.29 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.956 1.302 . . . . 0.0 109.204 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -136.09 139.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 161.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.6 m -93.09 99.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 170.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -77.49 125.66 29.69 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.29 121.96 39.78 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.3 mm -108.55 107.78 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -70.03 110.1 4.91 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -32.16 70.16 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.94 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -21.36 65.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.214 1.406 . . . . 0.0 112.09 -171.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.79 8.04 3.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.692 1.197 . . . . 0.0 111.014 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.2 mt 34.1 60.62 0.55 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.793 2.437 . . . . 0.0 111.0 -165.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -123.5 144.88 49.26 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.04 0.536 . . . . 0.0 109.852 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 tt -83.42 94.41 7.98 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.6 m -74.89 -32.21 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.513 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.23 175.35 45.48 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.981 1.264 . . . . 0.0 111.962 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -137.98 149.32 46.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.537 0.668 . . . . 0.0 111.873 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -90.84 132.26 35.99 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.684 1.594 . . . . 0.0 108.872 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 p -76.56 164.59 58.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-N 120.39 1.45 . . . . 0.0 109.473 164.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.16 -54.18 3.93 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.33 2.687 . . . . 0.0 114.216 -175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.22 37.73 2.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.113 1.339 . . . . 0.0 109.995 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.47 -108.74 1.6 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 p -160.8 177.89 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -82.11 126.55 32.16 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.985 0.914 . . . . 0.0 110.229 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.6 142.34 28.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 162.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.18 148.17 51.99 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.66 0.784 . . . . 0.0 109.149 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.12 137.72 36.79 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.119 -0.988 . . . . 0.0 108.942 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 140.06 -177.03 20.91 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -155.37 130.9 9.75 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.123 1.769 . . . . 0.0 107.647 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 t70 58.58 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 128.34 2.656 . . . . 0.0 114.818 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.68 93.25 0.72 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -168.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -137.04 147.29 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.412 1.085 . . . . 0.0 108.653 -177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.5 m -80.46 71.95 7.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.1 145.91 49.27 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.956 -0.465 . . . . 0.0 110.162 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.34 1.78 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.64 153.91 26.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.584 1.538 . . . . 0.0 110.2 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.8 46.97 3.77 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.503 1.049 . . . . 0.0 114.117 -165.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.59 -142.63 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 168.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -101.43 93.55 3.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.264 1.826 . . . . 0.0 107.853 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.75 179.94 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.17 3.247 . . . . 0.0 111.351 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.37 153.49 51.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.455 -0.778 . . . . 0.0 110.243 161.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -82.48 153.54 25.56 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.297 0.639 . . . . 0.0 111.04 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.6 mt -75.16 -30.61 60.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.059 1.344 . . . . 0.0 112.0 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.45 4.54 60.8 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.177 -0.791 . . . . 0.0 113.413 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -142.92 159.74 41.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.972 1.309 . . . . 0.0 108.504 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.6 174.44 20.22 Favored Glycine 0 N--CA 1.467 0.754 0 C-N-CA 124.854 1.216 . . . . 0.0 111.081 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -95.83 96.62 1.97 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.402 1.001 . . . . 0.0 110.85 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.99 148.47 32.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.897 0.849 . . . . 0.0 109.555 171.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -55.56 -38.64 69.6 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 112.312 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.57 -24.93 66.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.176 0.591 . . . . 0.0 111.291 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.35 -12.98 61.01 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.518 -0.739 . . . . 0.0 112.453 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.35 -74.66 0.1 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 10.66 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.813 1.245 . . . . 0.0 111.295 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 -74.99 1.3 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 124.581 1.086 . . . . 0.0 111.76 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -73.73 -31.17 63.23 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.601 1.16 . . . . 0.0 112.89 -165.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -115.88 169.89 8.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.85 1.26 . . . . 0.0 109.341 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.63 -167.87 20.96 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.482 1.515 . . . . 0.0 111.902 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.51 -9.46 58.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.403 1.881 . . . . 0.0 115.263 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.33 -13.81 51.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.439 1.472 . . . . 0.0 112.608 -169.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.8 p -79.05 -1.73 37.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.817 0.847 . . . . 0.0 112.917 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.01 140.84 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.808 1.185 . . . . 0.0 110.598 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -82.04 156.5 24.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.884 1.274 . . . . 0.0 109.77 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 20.9 mmt -110.11 -178.6 3.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.837 2.055 . . . . 0.0 109.423 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.83 170.5 17.91 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 124.77 1.176 . . . . 0.0 111.148 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -68.43 -23.48 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.105 1.453 . . . . 0.0 114.409 -165.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.07 79.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.635 1.107 . . . . 0.0 108.896 171.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -72.66 -36.03 67.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.551 0.741 . . . . 0.0 110.722 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.0 ttm -61.56 -46.85 88.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.245 0.93 . . . . 0.0 109.941 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.6 m -62.15 -44.83 95.74 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 110.419 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -55.12 -54.37 44.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.104 0.866 . . . . 0.0 109.498 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.98 -57.54 12.61 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.111 0.964 . . . . 0.0 112.138 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.1 p -59.75 -38.48 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 118.678 0.672 . . . . 0.0 110.841 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -66.63 -46.2 76.58 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.107 0.867 . . . . 0.0 110.659 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -64.5 -36.09 83.06 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.13 -45.8 66.1 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.703 0.801 . . . . 0.0 110.387 172.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.07 -39.76 75.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.683 0.793 . . . . 0.0 111.51 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -75.61 4.2 8.12 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -69.51 24.13 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 120.462 1.483 . . . . 0.0 113.474 170.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -55.76 116.82 3.15 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.027 -1.67 . . . . 0.0 107.482 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 46.72 26.26 0.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.651 2.38 . . . . 0.0 115.402 -171.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.4 mmt -129.25 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.952 1.251 . . . . 0.0 111.017 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.2 tp -148.1 107.54 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 127.663 2.385 . . . . 0.0 104.636 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -116.45 94.01 41.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.425 1.09 . . . . 0.0 108.197 -172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.27 -25.65 73.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.845 2.363 . . . . 0.0 113.718 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -74.95 -16.85 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 112.031 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.83 164.68 16.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.916 0.78 . . . . 0.0 110.438 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -92.07 19.46 6.79 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.766 1.626 . . . . 0.0 111.671 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -49.86 -37.2 29.87 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.254 1.822 . . . . 0.0 111.575 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -65.02 -41.45 95.28 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.753 -1.217 . . . . 0.0 111.531 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.7 t -58.54 -43.15 89.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.829 0.74 . . . . 0.0 110.257 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -51.87 -56.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.188 0.595 . . . . 0.0 111.321 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.68 -37.86 85.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.705 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.63 -36.3 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 120.415 1.462 . . . . 0.0 110.028 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -63.83 -37.37 87.12 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.839 1.199 . . . . 0.0 111.669 174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 mt -61.68 -47.12 86.77 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.926 0.784 . . . . 0.0 110.247 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.47 -55.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.424 1.089 . . . . 0.0 109.298 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.54 -41.1 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.448 1.476 . . . . 0.0 111.771 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 ttp -65.44 -32.15 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.131 0.972 . . . . 0.0 112.079 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.89 -72.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.132 0.973 . . . . 0.0 109.979 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.95 -49.86 76.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.764 0.825 . . . . 0.0 110.791 -170.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.76 -40.78 69.1 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.83 -31.67 64.78 Favored Glycine 0 N--CA 1.467 0.721 0 C-N-CA 124.839 1.209 . . . . 0.0 113.728 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.69 -38.63 72.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.3 1.05 . . . . 0.0 110.686 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -83.35 -46.21 12.84 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.869 0.468 . . . . 0.0 110.279 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 198' ' ' VAL . 77.4 m-85 -103.86 84.97 2.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 126.126 1.77 . . . . 0.0 109.181 -172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.49 -17.48 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.972 -173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.4 m -54.87 -49.65 70.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.661 1.119 . . . . 0.0 111.91 167.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.92 -45.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.553 1.524 . . . . 0.0 109.491 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -44.59 96.73 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.753 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -71.82 -26.62 62.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.069 1.304 . . . . 0.0 113.01 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.4 m -62.04 -51.64 67.16 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.879 1.218 . . . . 0.0 108.526 167.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.79 -24.92 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 121.537 -0.727 . . . . 0.0 110.541 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.9 -42.19 77.22 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.935 1.694 . . . . 0.0 111.446 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.88 94.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -64.38 -34.31 89.56 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.22 0.914 . . . . 0.0 113.563 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.14 -30.43 69.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.805 1.642 . . . . 0.0 111.667 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.2 -26.41 64.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -78.73 140.78 38.25 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.21 -26.22 66.51 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.718 0.407 . . . . 0.0 111.651 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -74.82 -32.21 61.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.312 0.506 . . . . 0.0 111.252 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.97 -160.77 37.36 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -163.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.46 164.22 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.706 0.802 . . . . 0.0 110.202 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 1.4 p -122.64 109.26 14.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.636 2.374 . . . . 0.0 107.619 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.44 162.44 12.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.351 0.66 . . . . 0.0 111.114 173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 t -94.32 164.6 12.96 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.868 0.467 . . . . 0.0 109.923 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.59 -40.65 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.525 1.13 . . . . 0.0 110.804 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.0 m -56.84 -40.51 76.2 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.137 1.375 . . . . 0.0 110.849 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -64.21 -53.14 54.0 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -52.32 -41.36 54.64 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 123.616 0.627 . . . . 0.0 113.526 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.501 0.72 . . . . 0.0 109.936 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.31 -49.79 74.98 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.643 0.656 . . . . 0.0 111.351 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 171' ' ' PHE . 19.8 m -62.42 -33.24 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.75 0.704 . . . . 0.0 111.98 -169.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -84.38 -12.91 53.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.625 1.17 . . . . 0.0 112.13 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.11 55.59 1.57 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.082 0.944 . . . . 0.0 109.771 -175.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -56.21 -27.07 53.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.899 1.68 . . . . 0.0 112.126 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -55.87 -37.11 68.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.831 1.252 . . . . 0.0 110.961 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -75.95 -31.78 59.23 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.143 -0.973 . . . . 0.0 110.325 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 18.1 mm -64.09 -49.51 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 119.323 0.965 . . . . 0.0 108.761 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.7 p -64.28 -46.08 85.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.866 0.757 . . . . 0.0 110.582 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.71 84.87 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.989 0.813 . . . . 0.0 111.77 175.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.52 -44.72 90.0 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 119.536 1.062 . . . . 0.0 110.608 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.4 93.25 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.883 0.873 . . . . 0.0 110.491 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -63.35 -44.9 93.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.907 0.483 . . . . 0.0 110.921 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.36 -42.39 98.62 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.987 -1.07 . . . . 0.0 110.7 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 4.5 m0 -71.28 -8.07 51.2 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.81 1.244 . . . . 0.0 113.627 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -78.6 -31.94 47.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 120.198 1.363 . . . . 0.0 109.63 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.14 -38.98 20.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.158 0.983 . . . . 0.0 111.747 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -130.16 85.67 56.43 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.038 1.335 . . . . 0.0 110.059 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.74 -43.2 61.42 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.68 2.92 . . . . 0.0 114.827 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 2.9 t -84.98 -4.76 59.27 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.078 0.551 . . . . 0.0 112.398 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.24 165.53 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.208 -0.932 . . . . 0.0 111.519 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.3 146.89 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.65 103.6 50.51 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.15 -31.2 64.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.229 1.952 . . . . 0.0 111.851 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.33 -44.5 80.06 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.306 1.043 . . . . 0.0 109.589 172.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 27.9 tpp -68.0 -30.11 69.28 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.353 0.661 . . . . 0.0 111.043 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -66.82 -19.89 65.83 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.254 -0.904 . . . . 0.0 112.313 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.82 -10.86 59.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.783 1.174 . . . . 0.0 112.287 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -99.54 -18.06 17.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.14 1.376 . . . . 0.0 110.309 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 111.57 -14.53 27.35 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.693 1.616 . . . . 0.0 113.725 169.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mt -81.46 151.51 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -128.23 -26.78 2.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -137.78 158.27 44.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.843 1.201 . . . . 0.0 108.809 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -59.21 -32.42 69.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.993 0.815 . . . . 0.0 112.917 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.52 -33.08 74.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.405 1.002 . . . . 0.0 110.614 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.29 -46.11 78.09 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.68 78.56 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -36.93 80.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.135 0.974 . . . . 0.0 112.707 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.397 0.999 . . . . 0.0 111.949 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.53 -54.92 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.435 1.016 . . . . 0.0 110.639 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.5 152.43 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 120.06 1.3 . . . . 0.0 112.383 -174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.5 17.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.846 1.258 . . . . 0.0 111.192 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.65 173.23 11.8 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.621 1.168 . . . . 0.0 109.18 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.0 m -127.97 158.14 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.394 1.078 . . . . 0.0 110.489 166.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -56.64 159.14 4.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.879 1.272 . . . . 0.0 109.881 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.35 120.01 10.18 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.528 0.731 . . . . 0.0 111.307 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -117.18 32.62 6.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.326 . . . . 0.0 111.659 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.0 m -57.79 -34.41 69.58 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.108 -0.995 . . . . 0.0 110.765 175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.3 m -60.51 115.0 3.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.161 1.384 . . . . 0.0 109.796 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.34 62.98 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -105.78 103.68 13.23 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.263 1.425 . . . . 0.0 108.268 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.777 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttm 68.87 14.42 8.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.039 2.136 . . . . 0.0 114.01 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -107.92 172.88 6.58 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.401 1.001 . . . . 0.0 110.659 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.72 133.34 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.67 127.44 65.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.69 129.47 23.84 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.571 2.847 . . . . 0.0 112.916 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -85.6 -59.77 2.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.285 0.634 . . . . 0.0 110.072 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.05 150.04 45.3 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.18 1.392 . . . . 0.0 108.018 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 m -140.04 134.84 31.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -112.79 136.07 52.83 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.3 mt -116.63 130.72 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.38 146.32 60.49 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 123.184 0.593 . . . . 0.0 110.058 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.5 177.47 7.92 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.067 2.511 . . . . 0.0 110.223 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.72 -30.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.438 1.095 . . . . 0.0 110.575 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.3 -16.1 63.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.442 1.097 . . . . 0.0 112.839 -163.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.26 130.11 44.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.926 1.69 . . . . 0.0 107.122 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.25 63.86 2.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.939 0.895 . . . . 0.0 110.071 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 -39.63 17.9 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.467 0.707 . . . . 0.0 112.184 -166.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -111.03 144.58 30.67 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.996 1.318 . . . . 0.0 109.795 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.23 141.78 77.06 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.436 2.091 . . . . 0.0 110.526 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' CE2' HG22 ' A' ' 178' ' ' VAL . 15.8 m-85 -62.65 -35.31 79.2 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 121.438 -0.789 . . . . 0.0 110.564 167.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -57.39 -43.6 83.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.753 0.706 . . . . 0.0 109.457 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.37 74.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.613 0.765 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -54.75 -51.21 66.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.413 0.685 . . . . 0.0 110.901 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -58.72 -45.69 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.256 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.03 -46.07 78.97 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.523 1.056 . . . . 0.0 111.323 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 m -53.03 -45.45 68.0 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.737 1.153 . . . . 0.0 111.422 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.79 -48.08 77.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -55.48 -51.28 67.49 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.301 1.44 . . . . 0.0 110.949 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -55.86 -41.65 74.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.374 0.67 . . . . 0.0 110.385 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.78 -55.61 16.33 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.946 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.88 -28.39 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 118.721 0.691 . . . . 0.0 111.606 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.19 -35.61 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.821 1.191 . . . . 0.0 110.944 173.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -73.17 -12.62 60.95 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.029 -1.044 . . . . 0.0 112.132 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -124.83 -3.1 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.587 1.155 . . . . 0.0 112.893 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.3 p -85.65 174.82 9.13 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.971 0.805 . . . . 0.0 110.831 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -72.62 153.96 40.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.325 1.05 . . . . 0.0 109.431 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.26 162.23 7.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.457 0.646 . . . . 0.0 110.775 168.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -125.32 130.98 53.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.227 1.411 . . . . 0.0 108.109 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -83.34 -88.95 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.41 -0.07 58.24 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.239 0.923 . . . . 0.0 112.166 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.7 140.85 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.49 -53.31 7.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.545 0.688 . . . . 0.0 109.566 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -71.88 151.27 93.06 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.67 1.588 . . . . 0.0 110.694 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.1 159.89 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.937 2.425 . . . . 0.0 112.64 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.7 t -125.34 127.75 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 107.282 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.68 157.29 79.81 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 119.144 0.884 . . . . 0.0 112.235 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.98 158.88 41.0 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.732 2.954 . . . . 0.0 111.818 164.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.64 149.92 89.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.208 1.939 . . . . 0.0 109.773 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 40.2 tt0 -72.02 131.22 42.6 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.338 -0.226 . . . . 0.0 110.868 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -130.97 152.4 50.33 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.334 1.053 . . . . 0.0 109.555 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.32 -7.93 57.25 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.465 0.706 . . . . 0.0 112.381 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.18 72.25 60.08 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.722 1.209 . . . . 0.0 109.572 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.44 163.84 36.64 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.654 2.236 . . . . 0.0 110.906 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -84.18 -50.66 7.71 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -138.15 155.17 48.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.513 1.125 . . . . 0.0 110.522 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -166.56 174.65 8.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.585 1.954 . . . . 0.0 108.657 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.6 118.63 29.37 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.52 125.74 43.84 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 160.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.7 m -126.28 140.64 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.7 117.52 18.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.188 0.904 . . . . 0.0 108.949 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.7 122.83 34.61 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -104.73 150.98 24.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.723 1.609 . . . . 0.0 107.793 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.8 p -126.25 -178.61 4.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.632 1.173 . . . . 0.0 108.633 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.4 -14.64 52.44 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.355 -0.841 . . . . 0.0 112.988 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -34.05 2.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.69 1.196 . . . . 0.0 112.174 -168.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -146.51 -178.64 6.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.122 0.969 . . . . 0.0 110.777 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 p -152.25 165.14 35.79 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.179 -0.951 . . . . 0.0 108.829 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.5 pt -136.42 134.28 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.67 109.01 21.85 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 127.15 53.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.159 1.384 . . . . 0.0 107.485 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.92 120.85 41.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.4 mm -102.16 110.74 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -65.12 101.41 0.52 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -35.13 38.92 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 123.945 0.898 . . . . 0.0 110.452 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -55.15 -25.19 30.47 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 127.569 2.347 . . . . 0.0 113.697 -176.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.88 6.16 3.14 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.226 -0.921 . . . . 0.0 111.68 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.5 mt 37.97 61.19 1.1 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.487 1.915 . . . . 0.0 109.691 -163.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -127.29 137.97 52.96 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 tt -81.81 100.39 9.54 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.24 -41.77 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.459 0.572 . . . . 0.0 110.011 -174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 172.43 43.89 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -130.57 144.98 51.78 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.71 0.804 . . . . 0.0 109.868 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -78.83 143.65 35.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.106 1.762 . . . . 0.0 108.835 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p -108.54 158.3 34.31 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 162.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.75 105.86 0.69 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.284 2.656 . . . . 0.0 110.529 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.77 -60.61 0.3 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.25 59.78 0.09 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.412 1.006 . . . . 0.0 110.886 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 153.02 17.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD1' HD12 ' A' ' 102' ' ' LEU . 11.1 m-90 -124.23 138.37 54.41 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.33 95.26 6.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.775 1.63 . . . . 0.0 108.349 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.06 142.9 43.68 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -81.21 173.52 12.44 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 110.638 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.89 -162.16 48.74 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.53 151.25 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.668 1.587 . . . . 0.0 107.487 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 65.85 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.274 2.63 . . . . 0.0 113.552 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.51 63.8 1.75 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.162 0.887 . . . . 0.0 111.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -62.81 125.95 25.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.843 1.657 . . . . 0.0 110.133 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -93.64 135.64 34.71 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.128 0.571 . . . . 0.0 110.03 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -77.67 9.21 3.58 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.156 -0.965 . . . . 0.0 112.63 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.74 -40.55 63.18 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 120.969 -1.082 . . . . 0.0 110.421 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 90' ' ' TRP . 3.2 mm? -69.06 -2.64 10.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.346 1.058 . . . . 0.0 112.52 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.85 -93.2 1.6 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.31 160.31 21.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -57.87 116.61 14.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -78.29 -179.7 5.69 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.563 2.176 . . . . 0.0 109.397 172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -135.37 155.63 50.26 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.675 -0.641 . . . . 0.0 109.33 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -80.81 166.56 20.84 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.297 0.373 . . . . 0.0 110.608 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.8 mt -100.56 -3.05 31.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.998 0.919 . . . . 0.0 112.056 167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.09 -68.85 3.37 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -87.18 134.6 33.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 162.64 80.73 0.04 OUTLIER Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -148.34 -74.53 0.02 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.81 174.75 10.2 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.164 0.986 . . . . 0.0 110.407 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -55.89 -27.83 53.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 113.055 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -29.37 68.67 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.43 -0.794 . . . . 0.0 112.01 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -71.32 -24.74 62.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.382 0.673 . . . . 0.0 111.009 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.18 -66.41 0.73 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.811 0.845 . . . . 0.0 108.926 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.16 -22.75 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -171.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.93 -102.6 0.94 Allowed Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.34 0.973 . . . . 0.0 110.694 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.63 -24.33 49.56 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -165.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 154.22 26.25 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.06 -175.52 17.45 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.973 1.273 . . . . 0.0 110.619 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.27 -7.34 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -57.77 -18.81 23.83 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.265 1.393 . . . . 0.0 114.168 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.6 p -72.56 -15.57 61.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.126 1.37 . . . . 0.0 113.091 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -90.62 145.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.901 1.228 . . . . 0.0 110.097 -171.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 39.3 m -105.82 113.13 26.5 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.435 ' H ' ' HE3' ' A' ' 129' ' ' MET . 4.0 mtm -71.95 114.41 10.02 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.315 1.046 . . . . 0.0 108.567 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 165.73 39.1 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -33.58 71.21 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.338 1.569 . . . . 0.0 114.063 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.05 79.49 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.762 0.425 . . . . 0.0 110.506 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.41 -49.14 76.67 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.994 0.918 . . . . 0.0 109.309 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.8 ttm -67.35 -43.36 81.7 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.304 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 m -55.99 -54.6 42.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.68 1.127 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -61.69 -44.63 96.58 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.612 0.642 . . . . 0.0 110.859 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.71 81.53 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 118.508 0.594 . . . . 0.0 110.776 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.82 -49.35 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.933 0.788 . . . . 0.0 109.428 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.52 -48.15 82.76 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.561 0.619 . . . . 0.0 110.199 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.57 -34.93 74.87 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.301 0.641 . . . . 0.0 111.799 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.66 -36.88 73.58 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.724 -0.61 . . . . 0.0 110.897 173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.48 93.93 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.429 0.559 . . . . 0.0 111.451 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -76.58 -25.1 53.62 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.748 -1.12 . . . . 0.0 113.489 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -70.91 135.06 47.74 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.782 1.628 . . . . 0.0 108.48 172.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -131.83 16.55 4.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.197 0.999 . . . . 0.0 110.927 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -122.18 148.27 45.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.679 1.592 . . . . 0.0 107.592 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.42 38.78 0.31 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.738 1.615 . . . . 0.0 111.867 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.4 tp -144.4 157.08 44.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.887 1.275 . . . . 0.0 109.098 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.34 91.87 2.1 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.032 1.333 . . . . 0.0 109.209 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.58 -71.09 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.999 2.466 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -104.37 -6.57 20.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.075 1.35 . . . . 0.0 111.752 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.49 -26.77 66.53 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.018 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.1 33.45 4.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.099 1.76 . . . . 0.0 112.54 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -18.81 62.75 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.934 -1.104 . . . . 0.0 112.69 -164.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -53.67 33.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.745 1.157 . . . . 0.0 110.839 166.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -42.82 92.77 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.749 -1.219 . . . . 0.0 110.307 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -68.17 -23.22 64.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.981 -1.009 . . . . 0.0 113.187 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.78 -30.78 24.34 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.452 1.478 . . . . 0.0 112.311 167.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 162' ' ' VAL . 46.7 t -63.39 -42.27 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 120.79 1.632 . . . . 0.0 110.169 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -54.61 -39.33 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.448 1.022 . . . . 0.0 111.649 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 25.3 mt -67.05 -51.78 50.38 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.609 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 159' ' ' VAL . 6.9 p -62.15 -34.99 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.921 1.237 . . . . 0.0 110.523 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.8 -52.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.308 0.958 . . . . 0.0 109.043 175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.418 ' CG ' HG21 ' A' ' 178' ' ' VAL . 35.5 ttm -55.89 -43.91 77.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 111.715 -175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.13 -69.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.894 0.877 . . . . 0.0 109.276 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 11.3 t -72.27 -48.84 39.46 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 121.75 -0.594 . . . . 0.0 110.253 -165.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -72.76 -27.41 62.0 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.897 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.11 -37.86 87.54 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.209 -0.932 . . . . 0.0 112.53 165.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.6 -22.59 67.01 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.883 1.341 . . . . 0.0 111.785 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -89.25 -33.27 17.03 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.292 0.951 . . . . 0.0 111.526 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.543 ' CD1' HG12 ' A' ' 198' ' ' VAL . 57.1 m-85 -118.56 106.1 12.3 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.977 1.311 . . . . 0.0 111.017 -171.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -53.77 -33.8 57.01 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.599 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.1 m -55.79 -61.76 2.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.65 1.114 . . . . 0.0 110.702 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 198' ' ' VAL . 69.0 t -60.2 -40.75 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.656 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 -57.19 10.35 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.459 0.703 . . . . 0.0 110.126 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -66.55 -29.94 70.14 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 120.939 -1.101 . . . . 0.0 112.148 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.7 m -60.79 -59.28 5.64 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.089 0.859 . . . . 0.0 109.213 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 21' ' ' TYR . 12.9 p -63.11 -30.68 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.347 0.976 . . . . 0.0 110.545 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.33 -51.07 65.88 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.719 1.207 . . . . 0.0 111.554 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.36 82.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.907 0.483 . . . . 0.0 110.657 174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.51 81.47 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 123.944 0.783 . . . . 0.0 113.781 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -56.35 -55.37 34.34 Favored 'General case' 0 C--N 1.334 -0.073 0 C-N-CA 125.181 1.392 . . . . 0.0 110.506 -171.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.31 -28.49 47.46 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.636 0.774 . . . . 0.0 112.273 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.0 t -58.63 131.78 51.87 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 109.876 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.41 -35.4 79.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.805 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -73.62 -29.03 62.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.572 0.349 . . . . 0.0 110.587 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.35 -167.92 52.9 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.79 167.48 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.634 0.773 . . . . 0.0 109.604 172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.5 p -128.77 173.49 10.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.857 2.063 . . . . 0.0 108.181 173.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -176.33 4.18 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.949 1.3 . . . . 0.0 108.846 169.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 t -124.18 157.5 34.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.78 1.232 . . . . 0.0 107.891 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.1 m -45.6 -34.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.998 1.319 . . . . 0.0 113.874 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 m -51.88 -41.3 61.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.208 1.367 . . . . 0.0 111.806 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.4 -36.95 71.56 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.375 -0.828 . . . . 0.0 110.088 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -55.24 -49.65 62.78 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -62.89 -34.73 78.02 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.263 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -66.83 -47.17 72.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 174' ' ' VAL . 22.5 m -74.4 -35.32 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.742 0.701 . . . . 0.0 112.367 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -64.04 -46.49 84.18 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.501 0.721 . . . . 0.0 110.593 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -110.18 58.14 0.61 Allowed 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -53.18 -26.23 16.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.364 1.866 . . . . 0.0 112.419 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -47.48 -35.54 8.86 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.045 1.738 . . . . 0.0 112.225 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.2 -55.95 25.42 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.77 1.228 . . . . 0.0 111.094 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.14 -35.2 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.2 t -58.15 -55.4 35.39 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.847 0.748 . . . . 0.0 111.529 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -38.98 92.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.077 -1.014 . . . . 0.0 111.448 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -44.64 85.13 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 122.873 0.469 . . . . 0.0 111.032 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.41 -47.92 80.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.465 1.106 . . . . 0.0 111.003 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -61.55 -40.71 95.67 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.856 0.462 . . . . 0.0 111.183 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -64.8 -44.27 90.5 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.292 -0.88 . . . . 0.0 110.584 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -65.36 -11.57 43.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.229 1.411 . . . . 0.0 113.316 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -71.89 -48.88 42.64 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.909 -1.12 . . . . 0.0 109.485 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.04 -42.6 62.97 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.731 0.812 . . . . 0.0 110.854 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -122.89 108.18 32.9 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.18 -26.52 82.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.918 2.412 . . . . 0.0 115.307 -163.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 10.7 t -140.58 52.47 1.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.395 1.093 . . . . 0.0 109.504 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.54 11.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 165.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.63 126.68 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.66 99.54 35.63 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.51 -23.32 50.35 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.56 2.174 . . . . 0.0 112.465 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -59.65 -47.59 85.0 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.508 0.723 . . . . 0.0 109.415 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 2.2 tpp -78.7 -23.37 45.62 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.343 0.657 . . . . 0.0 112.003 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -56.91 -36.82 70.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.925 0.784 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -62.41 -29.17 70.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.759 0.709 . . . . 0.0 111.88 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -89.97 3.75 52.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.952 1.301 . . . . 0.0 111.336 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 87.24 14.38 64.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.46 1.028 . . . . 0.0 113.337 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.2 120.75 65.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.939 1.37 . . . . 0.0 107.374 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.84 -12.68 9.16 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -151.75 155.21 37.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -169.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.48 -37.92 65.82 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 112.034 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -67.86 -35.84 79.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.91 0.777 . . . . 0.0 110.333 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.77 -48.5 74.26 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.7 82.97 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.746 -0.596 . . . . 0.0 111.332 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -62.32 -33.01 73.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.767 1.227 . . . . 0.0 112.792 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -85.94 -14.79 43.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.868 0.758 . . . . 0.0 112.465 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.44 -49.33 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.278 1.031 . . . . 0.0 110.151 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.26 145.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 120.022 1.283 . . . . 0.0 111.344 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -83.2 -33.45 26.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.286 1.434 . . . . 0.0 111.46 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.37 171.63 16.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.179 2.192 . . . . 0.0 107.973 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 5.3 m -129.09 161.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.197 1.399 . . . . 0.0 109.728 166.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.91 171.91 7.34 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.395 1.078 . . . . 0.0 109.334 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -69.26 84.73 0.38 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.394 -0.816 . . . . 0.0 109.832 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -78.99 -46.82 17.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.5 m -39.56 107.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.145 2.578 . . . . 0.0 111.931 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.25 41.2 p 52.88 -0.19 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.338 3.055 . . . . 0.0 116.264 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.83 16.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.953 1.301 . . . . 0.0 110.994 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -149.31 162.35 40.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.422 1.089 . . . . 0.0 110.039 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.854 1.662 . . . . 0.0 108.252 178.052 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.993 0.425 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.41 -7.48 32.03 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -78.92 81.74 5.17 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.38 142.05 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.79 127.61 26.17 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -53.34 155.11 13.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.135 2.556 . . . . 0.0 112.797 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -65.62 -40.46 92.61 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -137.98 161.1 37.57 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.71 1.604 . . . . 0.0 108.498 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -136.51 145.65 45.33 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -109.67 150.0 28.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -135.3 132.82 52.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -123.94 103.02 34.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.048 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 95.58 0.85 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.921 3.081 . . . . 0.0 109.516 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.25 -42.07 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.936 0.895 . . . . 0.0 110.973 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.81 0.21 18.83 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.854 0.862 . . . . 0.0 112.112 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -132.29 37.42 3.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.783 1.233 . . . . 0.0 110.72 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.46 56.97 0.52 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.823 1.249 . . . . 0.0 110.842 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -67.55 -53.4 28.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.029 1.331 . . . . 0.0 109.208 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -65.8 153.67 90.63 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.22 1.008 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.67 134.0 39.08 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.739 2.293 . . . . 0.0 111.283 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.81 -40.51 92.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.891 1.276 . . . . 0.0 111.0 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 t -54.8 -43.86 73.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.303 0.641 . . . . 0.0 110.63 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.98 85.1 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.133 0.879 . . . . 0.0 111.787 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.89 -54.46 44.81 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.6 mm -60.53 -40.4 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.007 0.923 . . . . 0.0 109.9 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.8 95.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.802 1.241 . . . . 0.0 111.577 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.4 t -59.02 -44.13 91.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.671 0.668 . . . . 0.0 109.98 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.4 t -61.39 -46.95 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -60.38 -43.28 96.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.343 -0.848 . . . . 0.0 112.067 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.45 -44.19 68.69 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.453 1.024 . . . . 0.0 110.564 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -72.59 -39.99 66.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.61 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -34.32 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.826 1.194 . . . . 0.0 111.295 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.36 -34.52 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 119.318 0.963 . . . . 0.0 110.527 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -58.89 -43.51 91.0 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.103 0.961 . . . . 0.0 110.48 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -76.4 -32.59 58.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.592 1.157 . . . . 0.0 112.034 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.8 m -58.29 154.2 13.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.865 0.866 . . . . 0.0 112.925 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 m -74.54 158.01 34.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.275 1.83 . . . . 0.0 110.086 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -64.99 168.46 6.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 110.928 166.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -141.04 165.35 27.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.614 1.165 . . . . 0.0 112.073 -168.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.63 -158.12 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.25 1.42 . . . . 0.0 108.498 162.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.58 67.14 0.77 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 120.51 -1.369 . . . . 0.0 112.076 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.48 138.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 127.438 2.295 . . . . 0.0 105.627 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -72.96 -44.91 60.58 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.874 0.845 . . . . 0.0 109.656 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -66.57 135.27 94.52 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.763 2.425 . . . . 0.0 110.025 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.12 159.98 24.22 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.542 2.161 . . . . 0.0 111.705 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.2 t -112.59 148.11 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.366 1.466 . . . . 0.0 107.712 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -117.54 147.8 41.54 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.076 0.951 . . . . 0.0 110.862 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.22 131.21 44.46 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.98 3.12 . . . . 0.0 112.754 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.35 142.04 11.71 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.813 2.342 . . . . 0.0 111.026 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 31.61 70.79 0.09 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 129.326 3.05 . . . . 0.0 114.527 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -89.29 124.9 34.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.94 0.896 . . . . 0.0 108.858 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -73.84 -33.48 64.14 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.69 89.14 50.0 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.91 . . . . 0.0 110.831 -166.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 100.72 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.994 2.462 . . . . 0.0 110.177 174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -68.0 -26.49 65.93 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.523 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -143.38 158.99 43.18 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 126.563 1.945 . . . . 0.0 107.927 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -168.78 173.91 6.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.632 1.573 . . . . 0.0 109.531 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.48 118.9 30.31 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -128.86 127.23 41.45 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.1 m -137.6 124.87 21.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -164.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -96.92 102.84 14.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 62' ' ' LEU . 15.4 tp -80.06 116.63 20.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 173.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -130.78 150.0 52.16 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.14 -163.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -126.71 177.21 6.69 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.496 1.518 . . . . 0.0 107.428 168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -65.83 -10.38 37.4 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.82 -1.175 . . . . 0.0 112.464 168.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -39.04 4.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.774 1.63 . . . . 0.0 111.459 -167.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 m -151.33 169.85 20.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.614 1.166 . . . . 0.0 111.126 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -143.54 157.94 44.04 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.219 1.008 . . . . 0.0 109.784 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.7 pt -140.3 132.43 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.37 97.91 8.9 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -86.2 149.42 25.11 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.224 0.61 . . . . 0.0 109.778 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.89 107.15 12.79 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.064 1.345 . . . . 0.0 109.094 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.11 106.11 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -58.61 103.56 0.17 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.95 1.3 . . . . 0.0 107.838 167.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -56.67 -36.34 69.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.649 0.779 . . . . 0.0 111.434 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -40.87 53.7 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.909 2.084 . . . . 0.0 113.049 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -121.75 6.56 9.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.563 0.745 . . . . 0.0 111.621 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.7 mt 40.52 68.25 0.43 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.214 2.206 . . . . 0.0 109.627 -165.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.31 140.16 46.2 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.346 0.658 . . . . 0.0 110.214 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.6 99.8 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.64 -18.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.8 48.43 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 119.139 0.881 . . . . 0.0 111.872 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -142.21 161.61 37.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.471 0.708 . . . . 0.0 110.897 171.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -93.01 131.53 37.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.502 1.921 . . . . 0.0 108.672 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.7 p -82.02 127.86 70.36 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 161.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.42 -42.82 58.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.141 2.56 . . . . 0.0 114.323 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.65 29.04 12.33 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.659 1.123 . . . . 0.0 111.795 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.29 -130.63 1.7 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.593 1.092 . . . . 0.0 110.474 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 m -138.85 -176.72 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.507 1.523 . . . . 0.0 108.651 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -78.12 152.22 32.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.654 -0.654 . . . . 0.0 110.947 172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -130.4 105.01 7.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.128 2.171 . . . . 0.0 107.214 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -85.5 151.39 23.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.366 1.067 . . . . 0.0 108.943 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.45 160.98 31.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.448 0.699 . . . . 0.0 109.888 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.6 -174.87 52.15 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -154.52 165.24 37.07 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.258 1.423 . . . . 0.0 109.696 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.8 t70 74.03 -37.25 0.36 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.716 3.207 . . . . 0.0 113.633 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.39 107.78 2.2 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 165.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.5 118.33 16.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.12 164.49 29.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.624 1.969 . . . . 0.0 107.533 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -136.43 37.75 2.7 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.806 -0.559 . . . . 0.0 111.255 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.02 -37.38 71.64 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.387 -0.821 . . . . 0.0 110.159 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.88 -3.09 20.45 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.388 1.475 . . . . 0.0 112.666 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.69 -81.87 0.3 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.727 1.632 . . . . 0.0 109.505 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.84 169.34 18.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.83 118.52 49.48 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.361 -0.837 . . . . 0.0 108.9 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.52 -179.69 5.39 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.576 3.518 . . . . 0.0 110.462 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -93.92 179.85 5.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 160.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -121.48 135.9 55.0 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.978 0.911 . . . . 0.0 111.192 -165.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.29 -14.53 46.3 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.204 1.002 . . . . 0.0 112.957 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.28 -78.47 1.99 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.503 1.047 . . . . 0.0 111.016 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -69.99 167.85 16.66 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.452 1.101 . . . . 0.0 111.199 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 171.66 2.97 0.03 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.42 -176.06 46.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.296 1.548 . . . . 0.0 113.706 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.75 -179.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 129.938 3.295 . . . . 0.0 114.879 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -48.68 -39.9 26.12 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.615 1.566 . . . . 0.0 114.102 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.03 -39.91 87.51 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.558 -0.713 . . . . 0.0 110.872 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.98 -5.37 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.108 1.363 . . . . 0.0 112.205 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.62 -72.71 0.3 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.855 -1.153 . . . . 0.0 108.58 168.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 17.4 pt -142.83 26.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.559 1.144 . . . . 0.0 111.95 -161.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.96 -107.17 1.43 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.3 1.429 . . . . 0.0 111.585 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.86 -24.27 58.55 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.688 0.795 . . . . 0.0 112.371 -175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -80.13 164.45 23.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.42 159.29 14.15 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.917 0.77 . . . . 0.0 111.315 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -74.78 -4.23 36.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.95 -27.64 67.63 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.971 1.259 . . . . 0.0 111.917 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.39 7.44 11.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.549 1.14 . . . . 0.0 112.706 -164.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.19 127.07 72.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.993 -1.067 . . . . 0.0 109.37 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.4 m -78.94 151.38 31.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.276 1.031 . . . . 0.0 109.716 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 73.8 mtm -121.3 132.48 54.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.174 2.19 . . . . 0.0 107.274 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.11 166.73 33.33 Favored Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.56 -43.87 98.07 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.788 1.294 . . . . 0.0 112.241 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.91 -43.06 99.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.594 0.634 . . . . 0.0 109.92 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -61.48 -44.68 96.65 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 39.8 ttm -61.21 -44.48 97.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.618 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.0 m -56.09 -57.04 13.82 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.452 1.024 . . . . 0.0 110.396 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -61.5 -35.03 76.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.775 0.716 . . . . 0.0 111.467 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.68 83.63 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.255 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 67.5 t -56.07 -49.28 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.132 1.333 . . . . 0.0 109.813 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -58.29 -49.81 75.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.391 0.615 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.21 -26.47 63.89 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.282 1.033 . . . . 0.0 112.28 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.9 mt -81.68 -37.65 27.07 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.634 -1.291 . . . . 0.0 111.322 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.43 -32.73 68.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.352 0.978 . . . . 0.0 112.368 -174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -76.31 -10.94 59.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.12 90.72 7.1 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.977 1.262 . . . . 0.0 110.265 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -0.45 10.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 166.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -165.71 117.86 1.11 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.463 1.505 . . . . 0.0 107.285 160.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.27 173.29 15.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.764 0.826 . . . . 0.0 111.309 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 52.6 tp -144.08 -52.98 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.401 1.08 . . . . 0.0 109.807 159.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -141.97 81.01 14.9 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.19 -89.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.044 2.496 . . . . 0.0 110.684 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.9 -42.98 13.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.52 -179.21 7.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.256 1.422 . . . . 0.0 110.261 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -63.41 99.79 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.352 1.861 . . . . 0.0 109.906 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 p -49.33 -55.67 12.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.924 2.09 . . . . 0.0 111.689 -170.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.6 -37.59 84.48 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 123.979 0.911 . . . . 0.0 110.731 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 m -62.16 -49.03 77.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.864 1.211 . . . . 0.0 110.652 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.92 -31.12 72.12 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.687 -0.633 . . . . 0.0 111.768 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 pp -84.91 -40.74 16.67 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.036 0.834 . . . . 0.0 112.264 172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.446 ' HA ' HG12 ' A' ' 162' ' ' VAL . 73.8 t -69.42 -32.11 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.787 1.631 . . . . 0.0 111.143 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -23.97 67.55 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.467 -1.396 . . . . 0.0 111.955 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.79 -51.04 13.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.241 0.928 . . . . 0.0 110.351 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -58.58 -36.61 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.536 1.062 . . . . 0.0 111.094 -173.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.59 -39.8 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.034 0.833 . . . . 0.0 110.278 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.7 mtm -66.16 -44.25 84.64 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.401 -0.812 . . . . 0.0 111.003 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.67 -64.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.833 0.742 . . . . 0.0 110.034 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.63 -52.47 25.57 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.181 0.992 . . . . 0.0 110.075 -170.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.13 -43.58 82.03 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.941 -1.028 . . . . 0.0 108.601 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -48.63 -40.52 25.04 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.686 1.13 . . . . 0.0 112.609 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.2 tp -64.4 -55.27 22.15 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.009 0.924 . . . . 0.0 111.065 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -84.85 -21.91 29.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 198' ' ' VAL . 47.5 m-85 -96.06 177.86 5.6 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.67 1.188 . . . . 0.0 110.578 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -115.85 -56.33 2.34 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.485 1.514 . . . . 0.0 108.833 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -54.97 -48.59 73.04 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.972 0.806 . . . . 0.0 112.43 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.4 -27.35 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.323 -1.486 . . . . 0.0 110.78 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.8 t -60.52 -54.57 43.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.761 1.164 . . . . 0.0 109.666 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.52 -41.88 90.96 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.356 0.526 . . . . 0.0 111.036 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 60.9 m -61.77 -50.01 74.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.95 -59.41 4.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.84 -40.68 73.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.753 1.16 . . . . 0.0 112.659 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.8 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.399 0.679 . . . . 0.0 112.754 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.92 -9.06 21.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 124.264 0.935 . . . . 0.0 113.407 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.98 -41.11 97.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.201 1.501 . . . . 0.0 110.603 -168.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -97.03 10.21 39.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.125 0.57 . . . . 0.0 112.512 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.3 p -86.1 167.35 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.645 1.111 . . . . 0.0 110.493 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -71.39 -38.24 71.51 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.662 . . . . 0.0 112.189 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -92.88 -25.27 18.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.551 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 72.47 -172.9 47.44 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 119.47 1.032 . . . . 0.0 111.511 -168.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.75 168.68 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.218 1.407 . . . . 0.0 110.374 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 6.3 p -121.55 159.13 27.01 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.695 1.598 . . . . 0.0 108.949 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 190' ' ' LEU . 2.7 pt? -102.08 179.87 4.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.869 1.268 . . . . 0.0 109.104 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 t -117.71 159.03 23.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.315 1.046 . . . . 0.0 108.554 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.5 m -58.56 -27.73 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.746 0.818 . . . . 0.0 111.882 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.7 m -61.74 -43.89 97.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.877 0.871 . . . . 0.0 110.099 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -45.87 81.47 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -40.44 -60.39 2.04 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 125.227 1.394 . . . . 0.0 112.142 172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -51.55 -42.84 62.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.176 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -76.42 -36.83 57.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.337 0.517 . . . . 0.0 111.818 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 171' ' ' PHE . 20.0 m -78.69 -27.16 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.914 0.779 . . . . 0.0 111.777 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.95 -57.12 13.91 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.896 1.679 . . . . 0.0 111.209 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -107.06 82.54 1.7 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -53.06 -36.6 60.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.876 0.87 . . . . 0.0 110.422 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.17 -37.39 69.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.637 1.175 . . . . 0.0 112.888 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -75.29 -37.79 60.7 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.89 -1.131 . . . . 0.0 111.224 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 7.6 tp -73.99 -30.63 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 120.836 -1.165 . . . . 0.0 109.84 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -59.13 -52.24 66.58 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.243 1.417 . . . . 0.0 110.041 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.42 75.64 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.666 -1.271 . . . . 0.0 111.984 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.3 77.39 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.584 1.084 . . . . 0.0 109.949 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.01 -43.14 86.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.256 0.622 . . . . 0.0 111.418 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.49 -44.03 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.581 0.752 . . . . 0.0 111.103 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.88 -36.32 82.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' TRP . . . . . 0.431 ' CD2' HD12 ' A' ' 219' ' ' ILE . 1.6 m0 -70.27 -9.06 54.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.808 1.243 . . . . 0.0 113.321 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.7 5.53 Favored 'General case' 0 C--O 1.23 0.05 0 O-C-N 120.53 -1.356 . . . . 0.0 109.967 -176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -77.05 -21.36 54.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.22 0.608 . . . . 0.0 112.528 -167.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -124.35 105.84 30.76 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.875 1.67 . . . . 0.0 106.855 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -42.47 -49.68 6.17 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.24 3.96 . . . . 0.0 116.837 -160.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . 0.253 15.2 t -141.86 69.57 1.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 123.225 1.488 . . . . 0.0 108.294 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -59.76 170.33 1.15 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.021 166.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.66 138.1 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 165.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 211' ' ' TRP . 16.5 mt -128.8 103.37 19.13 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.0 -17.6 51.36 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.526 2.151 . . . . 0.0 113.163 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -58.39 -30.35 66.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.725 0.693 . . . . 0.0 111.138 172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' MET . . . . . . . . . . . . . 13.7 tpp -120.37 -2.52 10.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -163.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.64 -33.66 71.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.952 0.796 . . . . 0.0 111.488 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -61.46 -24.84 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.695 -0.628 . . . . 0.0 112.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.44 0.9 56.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 111.097 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.18 86.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.43 1.014 . . . . 0.0 113.306 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 236' ' ' ILE . 10.9 mt -87.36 90.42 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -94.93 -5.13 45.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.439 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -140.88 147.52 39.03 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.477 1.111 . . . . 0.0 108.699 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -59.67 -30.72 68.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.158 0.583 . . . . 0.0 111.51 170.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -60.14 -39.77 87.47 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.281 0.633 . . . . 0.0 109.884 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -71.46 -39.35 71.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.27 -35.99 72.6 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.761 -1.212 . . . . 0.0 112.004 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.59 91.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.972 0.909 . . . . 0.0 111.631 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -69.15 -20.02 64.02 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.144 -0.973 . . . . 0.0 111.761 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 227' ' ' ILE 0.251 1.7 mp -90.02 -56.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.001 176.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.12 141.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 121.354 1.888 . . . . 0.0 110.684 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -94.48 -42.88 8.61 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 123.807 0.843 . . . . 0.0 110.798 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.97 154.05 46.02 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.214 0.915 . . . . 0.0 108.572 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.2 162.54 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.899 0.88 . . . . 0.0 110.172 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -76.22 162.2 28.15 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -70.34 107.96 4.01 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 158.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -88.58 119.11 28.74 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 2.3 m -67.33 -31.55 71.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.416 0.553 . . . . 0.0 110.497 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -150.47 167.43 27.18 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.91 1.284 . . . . 0.0 108.571 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -69.64 115.33 8.76 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.55 133.48 55.87 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.431 0 C-N-CA 125.99 1.716 . . . . 0.0 107.587 174.226 . . . . . . . . 0 0 . 1 stop_ save_